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ABSTRACT 
Standard diagnostic tools used from patient samples, specifically from blood draws, 
require specialized equipment, personnel, and facilities. Conventional techniques can often be 
very laborious and time consuming due to required sample preparation. The evident delay from 
sample collection to a patient’s result immensely impacts their outcome. The aims of this 
research are to design diagnostic biosensors that decrease time-to-results, minimize reagent and 
sample handling, and incorporate automated simple optical transduction and user interfaces for 
the detection of blood-derived biomarkers. Specifically, four biosensing detection mechanisms 
performed on 3 different point-of-care platforms will be discussed.  
First is a static loop-mediated isothermal amplification (LAMP) of nucleic acid aqueous 
droplet on a silicone chip platform immersed in mineral oil. The target-of-interest is a nucleic 
acid sequence as a biomarker for antibiotic resistant bacteria. The biosensing technique used 
related changes in interfacial tension (IFT) at the water-oil interface by measuring the change in 
contact angle (geometrical-effects) over time. Initially the system was characterized as a linear 
response in relation to concentration of bacteria in a buffer system down to the limit of detection 
(LOD) of 100 CFU per µL. Subsequently, with the addition of bacterial infected blood sample 
models, the system became a binary assay (i.e. yes or no) as low as 10 CFU per µL within 10 
min of reaction.  
Secondly, a two-layered, paper microfluidic chip was utilized to quantify cancer cells 
from a buffy coat sample matrix by two detection mechanisms: 1) on-chip particle enumeration 
via smartphone microscope and 2) capillary flow dynamics via smartphone video processing. 
The assay resulted in a LOD as low as 1 cell per µL for the on-chip imaging aspect of platform 
and 0.1 cell per µL for the capillary flow analysis within 13 to 22s post application of blood 
sample.  
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Lastly, the same concepts previously described in the first platform utilizes changes in 
IFT due to amplicon presence in an aqueous solution immersed in mineral oil. An emulsion 
LAMP platform was investigated to determine the relation between angle-dependent light scatter 
intensity (based off Mie scatter theory) and nucleic acid amplification progression. The 
phenomenon attributing to changes in light scatter intensities is due to the interfacial changes 
occurring in the emulsion droplets, where amplicon amount increases the IFT decreases, 
resulting in smaller diameter emulsions. Changes in light scatter intensity within 3 min of the 
reaction shows statistical difference in comparison to no target control (NTC) for 103 CFU per 
µL of bacteria dosed into aqueous sample. These four detection mechanisms and three platforms 
offer but a few alternatives as biosensing methods for blood-derived diagnostic biosensors.  
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INTRODUCTION1 
Challenges in developing rapid diagnostic tools for blood-derived biomarkers 
Molecular analytics of patient samples such as tissue biopsies, blood, urine, and saliva is 
a routine process throughout the healthcare field, in which valuable information, whether it be 
for preventative monitoring purposes, diagnostic reasons, or prognostic decisions, is revealed. 
The assays which are performed on these samples require costly equipment, expensive reagents, 
and trained personnel, that are usually conducted off-site in a specialized facility. Therefore, 
patient results, or time-to-results, are inevitably delayed due to the need to transport samples to 
controlled environments[1].   
Specifically, for bloodstream infection identification with antibiotic 
resistance/susceptibility characteristics, hematology analysis, and immune-based assays, there 
have been numerous efforts in the scientific community to tackle the problem of prolonged time-
to-results. Such efforts have been addressed by the implementation of large systems that 
automate the process from sample preparation to specific-agent testing to reporting[2,3]. These 
systems have increased laboratory productivity, reproducibility, and diversity of tests, with 
reduced specimen turnaround time. However, these systems are large scale and high throughput, 
making them impractical for clinical settings, resource-limited areas, and field-use.  
Point-of-care and lab-on-a-chip 
 Point-of-care (POC) diagnostics are rapid, low-cost, mobile tests that can be conducted in 
resource-limited environments by minimally trained personnel. Conducting tests on site allows 
for faster time-to-results, which in turn improves opportunities for proper and adequate patient 
treatment [4,5]. The incorporation of microfluidics with POC tests add complexity and versatility 
                                                
1 Adapted from Ulep and Yoon. Challenges in paper-based fluorogenic optical sensing with 
smartphones. Nano Convergence. (2018) 5:14. – Published by SpringerOpen 
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to the assays due to controlled flow in discrete spaces, reduction in sample volume, minimized 
handling of reagents, and ability to run parallel comparison analyses[6]. 
 Lab-on-a-chip (LOC), is a subsection of POC that was inherently developed as a 
byproduct of biomedical engineers creating innovative and novel methods and technologies in 
which complex assays that require multiple reagents and steps throughout the process are 
miniaturized and precisely controlled in an all-in-once “chip” format[7]. Polydimethylsiloxane 
(PDMS) polymers are commonly used in fabrication of microfluidic LOC POC platforms. 
PDMS provides an optically transparent (230 – 1100 nm), flexible, nontoxic, and low-cost 
material. However, when untreated, the PDMS surface is relatively hydrophobic, which can be 
problematic in controlling flow especially under low pressure conditions. Also, irreversible 
protein adsorption to PDMS surfaces can eventually lead to a nonfunctional device. Although 
there have been many surface modification techniques developed, induced hydrophilic states are 
only temporary. PDMS inherent hydrophobicity will return after a period of time[8,9]. 
Furthermore, when developing unique infrastructures such as on-chip pumps and valves, PDMS 
lithography fabrication techniques require a clean room access, which in turn can become 
complex and expensive for prototyping. 
Paper microfluidics  
Alternatively, paper can be used as a microfluidic platform. It is inexpensive, easy to 
chemically modify (i.e. nitrogen functionalized cellulose is commonly used for biological 
samples), and easy to fabricate, store, and transport[10]. Additionally, due to the fibrous structure 
of paper, which results in capillary flow and wicking effects of reagents, obviates the need for 
external pumping, unlike silicone-based LOC. A widely known and highly used paper-based 
lateral flow assay (LFA) example is the colorimetric pregnancy test strip. The basic mechanism 
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utilizes a sandwich immunoassay. Immobilized antibodies on a paper substrate bind with target 
antigens if present in the applied sample. Subsequently, secondary antibodies conjugated to gold 
nanoparticles act as the reporter through binding to the antibodies immobilized on the paper with 
the captured antigens. The resulting positive diagnostic detection is the appearance of an 
aggregation-induced pink color [11]. The colorimetric indicator is due to a spatially dependent 
optical property of gold nanoparticles, known as the surface plasmon resonance band [12]. 
However, colorimetric LFAs are binary, i.e. yes-or-no assays, thus difficult to quantify in a 
reproducible manner. In addition, they show little potential for multiplexing capabilities since 
they can detect only one assay per strip. Also, commercially available LFAs require a high 
concentration of targets of interest in order to obtain a reliable signal that may not be within the 
normal or hyperactive physiologically relevant levels [11]. As an example, commercially 
available LFAs for detection of thyroid stimulating hormone (TSH) have a limit of detection of  
>5 mIU/ L, which fails to detect the normal and low concentrations of TSH (i.e. 
hyperthyroidism) in human blood serum [13]. Similarly, commercially available nitrite LFAs for 
recognizing Escherichia coli from urine (for detecting urinary tract infection), as well as 
Neisseria gonorrhoeae, the most common cause of sexually transmitted disease (STD) infection 
of the urogenital tract, havea limit of detection of 106 CFU/mL [14]. Urinary tract infections can 
have bacteria concentrations as low as 102-103 CFU/mL in adult patients [15] and even less in 
children [16]. In a thorough analysis of commercial assays for detection of Cryptosporidium in 
fecal samples, the ImmunoCard STAT! LFA platform failed to detect all 12 samples with <175 
organisms per 10 µL sample and had problems with interpretation due to low band intensity [17].  
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Biosensing techniques used in blood diagnostics  
Fluorescence 
Blood is a complex mixture of cells, proteins, and fluids; therefore detecting a target-of-
interest with a differential signal from background noise can become a challenge when 
developing diagnostic assays. Fluorescence can be a powerful tool in producing distinguishable 
signals due to its intrinsic mechanism which absorbs the excitation light at characteristic 
wavelengths unique to each fluorescent compound and then emits fluorescence having a 
complementary emission wavelength profile (see Figure 1).  The use of fluorophores to label 
targets-of-interest for diagnostic purposes are commonly used to identify nucleic acids, cells, and 
analytes.  
Fluorophores can be a dye that fluoresces only when bound to the target-of-interest. An 
example of a fluorescent dye that is commonly used to identify whole cell DNA is 4’-6-
diamidino-2-phenylindole (DAPI). Its excitation wavelength maximum is 358 nm, and 
corresponding emission maximum of 461 nm. DAPI when bound to the AT (adenosine-tyrosine) 
regions of double-stranded DNA (dsDNA) increases its fluorescent intensity by 20-fold. 
Fluorescent labeling of a cell nuclei can give information about apoptosis, morphology, size, cell 
count, and cell cycle status, and can also be used for sorting of single cells and nuclei[18]. 
Another example of a well-known DNA fluorescent stain is SYBR® Green, a dsDNA probe that 
intercalates between DNA base pairs. SYBR® Green is widely used to monitor the nucleic acid 
amplification of a target-gene-of interest in a real-time manner[19].  
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Figure 1. Example of excitation and emission spectrum of a generic fluorescent dye overlaid and 
showing two distinctive and unique peaks[20] 
For more specific fluorescent labeling, fluorophores can be conjugated to a bio-
recognition element such as an antibody or oligonucleotide that has a high affinity to the target-
of-interest. Fluorescent in situ hybridization (FISH) is a label and detection mechanism that is 
routinely used in diagnostics using patient blood samples. The biorecognition element in the 
FISH biosensing technique is a fluorescently labeled oligonucleotide whose sequence is 
complementary to the target single-stranded DNA sequence[21]. Specifically, in blood borne 
pathogen detection, FISH technologies are used to rapidly detect and identify positive bacteria 
blood cultures. In real-time the fluorescent intensity is monitored as a direct result of an 
increasing amount of target gene in the growing bacteria blood culture[22]. Antibody-conjugated 
fluorophores are widely used labeling tools for diagnostics. Specifically, cell labeling to specific 
proteins such as phalloidin or vinculin allows users to visualize the F-actin filaments and 
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cytoskeleton to determine cell type (normal versus cancerous) and induced response morphology 
[23] (see Figure 2).   
 
Figure 2. Fluorescence microscope images of cells stained with top left: DAPI intercalating dye, 
top right: Fluorescein isothiocyanate (FITC) conjugated to anti-vinculin, bottom left: 
Tetramethylrhodamine isothiocyanate (TRITC) conjugated to anti-phalloidin, bottom right: 
overlaid red, green, blue channel images into a single combined cell image[12]. 
 
Advantages of fluorophores are that they are widely used synthetic molecules rendering 
them easily accessible and relatively inexpensive. Fluorophores are very commonly used in POC 
and LOC platforms to reduce the limit of detection (LOD) of the target-of-interest. However, 
traditional fluorophores are known to photobleach when exposed to excessive amounts of light, 
therefore storage, stability, and long-term use are limited in POC applications.  
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Nanotechnologies combined with fluorescence detection has demonstrated the lowering of limit 
of detection for devices down to the single cell or picogram protein molecule resolution [24–27]. 
Implementation of fluorescent nanotechnologies such as quantum dots [28–30]and 
nanoclusters[31,32] have several advantages over more traditional colorimetric sensors. 
Nanoscale sensor sizes and shapes can easily be tuned to respond to specific excitation 
wavelengths, by varying shape, size, and length. Nanostructures possess large surface areas for 
accommodating increased amount of bioreceptor immobilization, and this in turn results in 
increased sensitivity and much lower limit of detection. Nanoparticles are also highly stable and 
do not photobleach as easily in comparison to traditional fluorescent dyes [33,34]. The resulting 
fluorescence emission spectrum provides increased sensitivity, which in turn results in increased 
signal-to-noise ratios. Lastly, the materials used in these nanotechnologies, such as carbon 
[35,36] and gold [37,38] show superior biocompatibility in complex biological matrices. 
Fluorogenics in combination with paper-based microfluidic devices, reduces cost, simplifies 
manufacturability, and improves ease of disposability[39]. Therefore, fluorescent 
nanotechnologies on paper-based platforms have become an extremely attractive option in 
biological and chemical sensing [40]. 
Nucleic acid amplification  
Nucleic acid amplification is another conventional detection modality commonly used for 
blood diagnostics. The Polymerase Chain Reaction (PCR) is a gold standard methodology that 
utilizes cyclic temperature shifts: 1) denaturation of dsDNA at 94-96°C, 2) annealing of primers 
at 50-65°C, and 3) extension of complementary sequence via a polymerase enzyme at 70-76°C 
(see Figure 3) to amplify targets. In turn, an exponential amount of colinear copies of the target 
dsDNA of interest are produced[41]. PCR usually requires the extraction of DNA from the 
  27 
pathogen-of-interest, such as a virus, bacteria, or cell (i.e. cancerous, normal) via a lysing 
process. An important component required in a PCR reaction are two primers: a forward and a 
reverse primer, which are complementary short sequences that oppositely tag on both sets of 
dsDNA. Four types of deoxy ribonucleotide triphosphates (dNTPs): adenine (A), thymine (T), 
guanine (G), and cytosine (C), which are the monomers of nucleic acids are then added in a 
complementary manner via a polymerase[12].  
 
 
Figure 3. The three-step process of the polymerase chain reaction (PCR) ¾ denaturing, 
annealing, and extension, which results in an exponential growth of linear target DNA as cycles 
are repeated. 
 
End-point analysis of a nucleic acid amplification reaction to verify production of 
amplicons has traditionally been done using gel electrophoresis. Gel electrophoresis exploits the 
intrinsic negative charge of DNA and its molecular weight dependent diffusion through an 
agarose gel matrix. When a current is applied across a gel, DNA moves through the gel at rates 
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dependent to its fragment size due to its attraction to the positive pole. This process can be very 
time consuming and laborious, therefore real-time methodologies were developed to monitor the 
progression of nucleic acid amplification as the reaction occurs.  
Quantitative PCR (qPCR) utilizes intercalating dyes such as ethidium bromide and 
SYBR® Green which have high affinity to nucleic acids by embedding between base pairs. As a 
result, fluorescence intensities can be monitored over time for various initial target concentration, 
resulting in standard curves that could be used to quantify unknown amounts of target sequence 
in samples. However, such intercalating dyes are non-specific in the sense that they will bind to 
any dsDNA. As a result, to address this problem complementary oligonucleotides to target 
sequences can be conjugated with a fluorophore to act as reporter. These hybridization probes 
allow for a cleaner fluorescent signals that are more specific and directly quantitative to the 
amount of target gene being amplified in real time[22].  
Overall, PCR has been shown to be a powerful diagnostic tool that provides a gold 
standard technology for clinicians and researchers alike. However, in blood diagnostics the use 
of PCR has its limitations due to the presence of inhibitors such as proteins (proteins, 
immunoglobulins[42], small molecules[43], and excess non-targeted DNA/RNA. Pre-processing 
of patient drawn samples, via purification and extraction of the target genomes, increases the 
assay time and delays time-to-results. Therefore, there is a need to develop techniques in which 
blood samples can be directly placed into nucleic acid reactions without signals being 
compromised. LOC and POC technologies have incorporated PCR into their platforms as a 
means to address the complex reagent handling, cyclic heating temperatures, and the bulky 
equipment required to run the reaction that reduce the complications of traditional PCR 
methodologies. Complex microfluidic chips have been designed and developed to intricately 
control flow, filter, and amplify whole blood samples to detect genes of interest[44–46].  
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Isothermal nucleic acid amplification technologies have gained popular interest amongst 
POC and LOC scientist/engineers. Amplicons are exponentially produced at a constant 
temperature and fast reaction times (~20 min), therefore rendering them an attractive technology 
to field and clinical settings since specialized heating and cooling equipment is no longer 
required[47]. Specifically, loop-mediated isothermal amplification (LAMP) is one of many 
isothermal techniques that have been utilized and even translated into commercially available 
kits. LAMP reactions are comprised components similar to those of PCR reactions, but differ 
significantly due to the use of 4 to 6 primers. Such primers include a forward, reverse, FIP, BIP, 
LoopB, and LoopF that essentially induces the annealing and extension via cyclic displacement 
of a target gene without denaturation. As a result, LAMP amplicons are high molecular weight 
and are dumbbell or cauliflower shaped [48,49]. 
Real-time progression of LAMP platforms have been extensively demonstrated, utilizing 
several detection methods, such as electrochemical[50,51], fluorescent[52,53], colorimetric[54–
56], and turbidimetric (due to magnesium pyrophosphate precipitation)[57,58] detection. 
However such sensing modalities can be susceptible to and therefore limited by changes in 
environmental conditions, such as inconsistent ambient lighting, and the need for external 
hardware (i.e. light sources, optical filters, and transducers). Alternative methods of measuring 
nucleic acid amplification can be conducted by measuring the interfacial tension changes of the 
aqueous nucleic acid amplification reaction. Harshman et al. (2015), utilized a moving droplet-
on-a-thermocouple PCR (DOTS qPCR) device that monitored the geometrical difference of a 
PCR droplet that traveled through a temperature gradient mineral oil bath providing the cyclic 
temperatures required. Due to the increased production of PCR amplicons, the droplet size 
decreased due to decreased interfacial tension. The DOTS qPCR platform was able to reduce 
time-to-results immensely in comparison to conventional nucleic acid amplification techniques 
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and showed significant amplification in complex sample matrices due to passive adsorption of 
protein molecules at the water-oil interface, thus separating inhibitors from compromising the 
efficiency of the reaction (see Figure 4) [59].  
 
Figure 4. Schematic illustration of competitive adsorption a the water-oil interface followed in 
the order of 1) protein adsorption (competitive inhibitors to PCR reaction), 2) protein 
conformational change at the interface, 3) replacement of denatured proteins with newly 
produced amplicons at the water-oil interface, 4) intercalation of SYBR® Green to amplicons at 
interface, 5) destabilization of interface due to decreased interfacial tension, and lastly 5) 
colloidal breakaway from the main PCR droplet.  
Smartphone sensing and interfacing for POC applications  
Smartphone optical sensing, utilizing its flash as a light source, its cameras as an optical 
detector, and potentially its software application for data processing is a potentially advantageous 
approach for POC applications. As a result, an easy-to-use, point-of-care, yet extremely sensitive 
handheld platform can be imagined. Smartphone integration has already demonstrated numerous 
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advantages and opportunities in its use as a detector and a user interface platform for POC 
assays. Smartphones also allow for network connection and access, on-board processing, and 
applications in resource-limited settings [39,40,60–62].  
As such, the number of publications in smartphone sensors have significantly increased 
over the past 5 years, as shown in Figure 5 (orange line). Expected next steps for smartphone 
sensing include its integration with paper-based platforms, its use in conjunction with fluorescent 
nanotechnologies, and combination of both, towards improving ease-of-use and sensitivity. 
However in 2017, for the first time, the total number of publications on the topic of smartphone 
sensing has started to decrease, potentially suggesting challenges in advanced smartphone 
sensing. 
The number of publications demonstrating fluorescent nanotechnology with smartphone sensing 
also showed the similar trend – a slow increase followed by a decrease in 2017 (Figure 5; yellow 
line), suggesting complications and challenges in demonstrating fluorescent nanotechnology with 
smartphone sensing. The number of publications demonstrating all of the above – smartphone 
sensing of fluorescent nanotechnology on paper-based platform is significantly smaller than 
overall smartphone sensing (Figure 5; light green line), again demonstrating its complications, 
although this number has continued to increase over time.  
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Figure 5. The number of research article publications on smartphone sensor (orange), those with 
fluorescent nanotechnology (yellow), and above two with paper-based fluorescent (light green) 
in the past 5 years. Clarivate Web of Science was used as the data source.  
 
Although there have been many publications and reviews attesting to these outlined 
advantages for paper-based fluorescent platforms, there has been a dearth of discussion on the 
challenges, technical limitations, and alternative methods of its fluorescent optical detection, 
especially in conjunction with smartphone sensing.  
Smartphone digital processing  
Digital enhancement  
 These days, the complementary metal oxide semiconductor (CMOS) array is the most 
widespread image sensor for smartphones. It utilizes Bayer color filter arrays (CFAs) that collect 
red, green, and blue (RGB) values from a grid-like structure. The raw data pixel values are 
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processed through a demosaicing algorithm, which fills in missing RGB values through 
interpolation, resulting in an RGB image. Following the demosaic algorithm, a denoising 
algorithm is then applied [63,64]. Data image processing varies widely across smartphone 
models and brands, as do the physical properties of CMOS image sensors. Recently, Fontaine 
[65] released a well-organized and detailed publication outlining the different CMOS schematics 
between smartphone models and brands as well as the evolution of the technology over the years. 
Specific variations include the spatial resolution between metal aperture walls, the color filters 
used, and the optical stacking thickness.  
In most paper-based point-of-care assays that utilize fluorescence, pixel intensities are 
extracted and converted into a concentration of a target of interest, i.e., molecules [66–68], 
proteins [69,70], whole organisms [71], or nucleic acids [72,73]. When trying to control and 
maintain constant lighting, white balance, focus, or exposure while running multiple assays, on-
board default camera settings on smartphones can be problematic, as they are constantly trying to 
“optimize” white balance, focus, and exposures. Of particular concern is the ability of the camera 
to resolve very small points of interest, such as the test line on a LFA, or fluorophore-loaded 
areas on paper microfluidic devices [39].  
To further refine the captured fluorescent images, it is also common to apply digital 
filters. Use of digital filters does not require physical adjustments to the overall optical setup. 
This in turn offers a low cost and simple method for correcting undesirable image flaws. In 
fluorescence imaging, excessive crosstalk, which is the inconsistent recognition from left to right 
views resulting in a blurry effect, is a typical correction to address [74,75]. 
 There have also been numerous publications investigating better extraction and 
interpretation of measured RGB pixel values from the smartphone captured images on paper-
based platforms. Different color spaces have been investigated to enhance paper-based pixel 
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intensities [62]. Shen et al. [76] describe color conversion analysis and quantification of 
colorimetric pH test strips, and developed a more sensitive and accurate method utilizing a 12 
region reference chart to account for variability in lighting conditions. The group also alluded to 
its use in fluorescence paper microfluidic data, although it has not yet been demonstrated. 
Yetisen et al. [40] have devised an image processing algorithm that transforms RGB values into 
non-linear, linear, tristimulus, then into 2D CIE 1921 chromaticity space, which showed 
improvements in mitigating variability due to focus, angle, lighting, and sensor type. The applied 
algorithm was also demonstrated using two different cell phones, an iPhone 5 (8 MP camera) and 
a Samsung I5500 Galaxy 5 (2 MP camera), thereby demonstrating interphone adaptability. 
McCracken et al. [77] demonstrated the use of a triple-reference point normalization as well as 
fast-Fourier transform pre-processing using two different smartphone models (the iPhone 5S and 
the Nexus 5X). The image processing reduced spatial variability due to inconsistent paper 
surface, shadows, and uneven background reflectance for paper-based microfluidic assays using 
absorbance, quenching, and scattering measurements.  
Ratiometric FRET 
Fluorescence Resonance Energy Transfer (FRET) is the mechanism in which a 
fluorescent signal is produced due to a transfer of electrons from a donor fluorophore to an 
acceptor fluorophore that is within Angstrom proximal distances. As a result, two distinctive 
wavelength peaks are generated and can be measured in a ratiometric manner. In order for this to 
be efficiently monitored, peak excitation and emission wavelengths must be sufficiently 
separated, while having an overlap in donor emission and acceptor excitation spectra [78–80].  
 Ratiometric measurements are attractive due to their inherent ability to correct for 
environmental factors (such as varied lighting conditions and/or optical transparency of medium, 
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especially useful on paper-based platforms) and to self-calibrate [81,82]. Fluorescent dyes, 
although having been popularly used to demonstrate FRET-based ratiometric assays, are 
susceptible to photobleaching [83]. More recently, the use of quantum dots [82,84,85] and gold 
nanoclusters [31] have been better choices for FRET-based sensors due to their inherent 
photostability and superior signal-to-noise performance [86].  
 With regards to its applications in smartphone-based paper platforms, ratiometric 
fluorescent intensities can be easily monitored by simple splitting of red, green, and blue 
channels in a captured image. Wang et al. [68] measured 803 nm fluorescent intensity in relation 
to blue emission of upconversion nanoparticles (NaYF4:Yb and Tm@NaYF4) on paper to detect 
organophosphate nerve agents. As depicted in Figure 2, Noor and Krull [81] demonstrated the 
use of a smartphone where associated green and red pixel values were measured to monitor a 
nucleic acid hybridization assay. An inverse relationship was shown with correlated FRET-based 
transduction of donor green-emitting quantum dots and acceptor Cy3 fluorescent dye acceptor 
through a R/G (red over green) ratio. Yu et al. [87] prepared a ratiometric fluorescent test paper 
for visualization and quantification of fluoride ions in environmental waters with the use of CdTe 
quantum dots. As shown in Figure 6, red and blue fluorescence intensities were inversely related 
with the addition of fluoride ions. 
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Figure 6. Ratiometric FRET to detect fluoride concentration of water samples on paper-based 
substrates: a test paper preparation; b F- detection in DI water; c in tap water; d in lake water  
Smartphone hardware  
Light sources 
Paper-based microfluidics has proven the ability to provide flow without the use of 
external pumps or high voltage power sources (necessary for most silicone or PDMS-based 
microfluidic devices), but rather by spontaneous capillary action amongst paper fibers (also 
known as wicking). With the addition of a fluorescence detection method for an analyte (protein, 
cell, or nucleic acid), a light source is required. When using fluorophores, specific excitation 
wavelengths are important in order to obtain the desired emission spectra. This being the case, 
most smartphone-based fluorescent assays incorporate external light sources, the most popular 
  37 
being a handheld UV lamp or separate LED [81,88,89]. Taking this into account, various 
platforms have been designed to accessorize and power an external light source having 
thespecific wavelength needed for fluorescent sensing on paper platforms.  
3D-printed plastic attachments that are custom-fitted to a smartphone is most often used, 
where a built-in LED can be housed along with additional reflectors, collimators, and filters to 
improve signals [90–92]. Such attached enclosures provide a controlled environment in terms of 
lighting and spatial distances to improve reproducibility between assays. However, smartphone 
dimensions and availability vary greatly across manufacturers and models (also by the use of 
protective cases and covers), making custom attachments undesirable due to its poor adaptability. 
Along with using an external light source, an external power source is also required.  
An innovative method of powering an external LED with the required excitation wavelength is 
the integration of a galvanic cell, also known as a fluidic battery. Fluidic batteries are foldable 
and stackable hydrophilic paper layers with printed hydrophobic wax barriers as shown in Figure 
7. With the application of a water droplet, the fluidic battery powers an LED until it is run dried. 
The main requirements of a fluidic battery are 1) electrolytes (i.e. AgNO3, AgCl3, AgNO2, or 
MgCl2), 2) electrodes (i.e. silver metals, aluminum metals, or magnesium foil), 3) salt bridges 
(i.e. containing NaNO3), and 4) conductive connections (i.e. copper tape) [93–95].  
Instead of using external light source, the white on-board LED flash on a smartphone can 
be also used as an excitation source to create a fully smartphone-integrated platform [96–99]. 
However, band-pass or low-pass fitted filters are often used to separate out exclusive 
wavelengths for excitation, as smartphone flashes generate “white” light [98,100].  
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Figure 7. Self-powered paper microfluidic device, utilizing origami paper and galvanic cell, for 
enzymatic (alkaline phosphatase) fluorescent assay with smartphone detection: a device 
layout; b paper folding; c top and side view of final assembly 
Optical filters 
 Typical means of isolating fluorescence emission include the use of optical filters. Low-, 
high-, band-pass, or other filters inserted prior to the receiving detector (i.e., the CMOS array 
sensor, the most common camera used for smartphones) increases the selectivity of emitted 
fluorescent light. Not only can these filters differentiate wavelengths, but can also serve as a 
means for controlling unwanted scattered and diffracted light. Two types of optical filters are 
commonly used for fluorescence detection. The first type is an absorption filter, in which 
absorption at the excitation wavelength is desirable and absorption at the emission wavelength is 
undesirable. In contrast, interference filter have low absorption at the excitation wavelength and 
high absorption at the emission wavelength. 
Interference filters are comprised of multiple thin layers of dielectric material with 
different refractive indices. Selectivity for the wavelength of interest is dictated by the 
mechanistic pathways that light travels at the fabricated boundary layers. UV excitation is a very 
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commonly seen in fluorescence nanotechnology (most notably quantum dots). This can be very 
problematic since the optimum excitation wavelength for cellulose paper is within the UV 
spectrum. Therefore, numerous UV filters have been developed to optimize the use of UV 
excitation in these devices. Other filters developed include a filter developed by Dattner and 
Yadid-Pecht [101], which is a transparent, poly-acrylic acid (PAA) emission filter, mounted on a 
low-light CMOS array sensor for selecting red fluorescence. Similarly, Richard et al. [102] 
fabricated a 9 layer interference filter to select 650 nm red emission from quantum dots with 532 
nm excitation wavelength. The final filter was integrated into a silicone-based (thus optically 
transparent) microfluidic device equipped with a CMOS array sensor (Figure 8).  
 
 
 
Figure 8. Interference filter added on a microfluidic device: a interference filter deposited on 
glass substrate (left) and patterned microfluidic channels on absorbing layer (right); b overall 
schematics 
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In comparison, absorption filters are comprised of one single layer. Absorptivity can be 
adjusted by the overall thickness of the filter and can be modeled using the Beer-Lambert Law, A 
= ε × l × c, where ε is the characteristic molar absorptivity of the filter, l is the path length or 
thickness of the filter, and c is the concentration of the absorbing material [101,103]. Absorption 
properties can also be controlled by the addition of dyes such as Sudan II [104,105], Orasol Red 
BL, KMPR® 1005 epoxy-based photoresist [102], Aptina green1, and Aptina red1 [106].  
Other unique filters can also be used to further enhance the fluorescent images that are collected. 
Lee et al. [107] demonstrated the use of a silo-filter comprised of metal lattices, which were used 
as dividends for individual pixels and light guides for fluorescent light to penetrate an absorptive, 
thick filter layer. The metal surfaces of the silo-filter contribute an enhanced scattering and 
reflectance effect, improving transmittance and overall background rejection. Photonic structures 
are also another widely used filtering component for controlling fluorescence emission by means 
of specifically patterned surfaces on gold [108] and plastic [109]. In an optofluidic chip 
developed by Ricciardi et al. [110], a fluorescence immunoassay was demonstrated for the 
detection of actin-actin antibody complexes with superior repeatability and a lower limit of 
detection. They utilized unique photonic structures for controlled light diversion into a 
fluorescence microscope apparatus. Similarly, Schudel et al. [111] developed a silicone-based 
microfluidic chip array that utilized Actuate-to-Open valve mixing and photonic crystal 
nanostructures to detect the binding of IgG to various proteins in an immunofluorescent assay 
using a charge-coupled device (CCD) array sensor.  
 
  41 
Addressing autofluorescence of paper  
It is widely known that cellulose-based paper substrates exhibit autofluorescence due to 
their treatment with optical-brighteners such as Calcofluor. Cellulose paper treated in this 
manner is strongly excited in the UV, generating blue/green emissions [112]. Therefore the 
unwanted background autofluorescence, along with back scattering from the paper surface, must 
be addressed. Also with the use of biological samples, autofluorescence and back-scattering light 
from paper surfaces can be even more problematic [113,114].  
Pulse excitation and time-resolved detection 
Traditional photo-detection instrumentations are designed to receive photons 
continuously during the excitation period. As a result, mitigation of unwanted background noise 
(especially autofluorescence) can be difficult. Pulse excitation and time-resolved detection are 
methods in which fluorophores are acutely exposed to an excitation light. From the collected 
fluorescent decay, a lifetime value can be determined that is unique to a fluorophore of interest. 
The measured lifetime can be crucial in resolving between background autofluorescence and 
detection-related fluorescence. Therefore, designation and separation of timed windows, short 
lifetime decays of autofluorescence (delay time) and long lifetime decays of fluorophores of 
interest (gate time), can be easily distinguished and collected as seen in Figure 9 [83,113,115].  
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Figure 9. Mechanism of time-resolved fluorescence as a means of eliminating short lifetime 
background and autofluorescence 
 
Ju et al. [115] developed lanthanide (Ln3+) doped GdF3 nanocrystals that successfully 
detected avidin protein under time-resolved fluorometric measurements with promising 
applications in immunoassays, multiplexing, and DNA hybridization. Wang et al. [83] 
demonstrated the use of time-resolved fluorescence in conjunction with ratiometric 
measurements using a smartphone on a paper-based platform to detect dipicolinic acid (DPA), a 
biomarker for anthrax presence. Lanthanide-terbium (Ln-Tb) and -europium (Ln-Eu) doped 
fluorescent crystals (Tb/DPA@SiO2-Eu/GMP) when exposed to a 254 nm UV lamp and DPA, 
resulted in an indicating red fluorescence, as opposed to a control green fluorescence signal. The 
spectra was further refined by using a delay time of 50 µs and gate time of 2 ms to avoid 
autofluorescence. Similarly, Kim et al. [116] demonstrated the use of time-resolved fluorescence 
measurements to study the enhanced fluorescence resonance energy transfer (FRET) efficiency 
and increased fluorescent lifetime of immobilized quantum dots on a paper platform in 
comparison to a solution assay. The four-fold enhancement in FRET rate was concluded and 
attributed to the decreased average distance between quantum dot donor and acceptor dye for the 
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paper-based platform. Overall, colored digital images were captured and analyzed under a 405 
nm UV LED to analyze trypsin proteolytic activity and inactivity in the presence of aprotinin 
inhibition. Paterson et al. [117] utilized a smartphone time-gated imaging application to capture 
images at set intervals after pulse excitation to detect human chorionic gonadotropin (hCG) with 
strontium aluminate nanoparticles on a LFA (Figure 10).  
 
 
 
Figure 10. Smartphone attachment utilizing the onboard “white” LED flash as a light source, 
using pulse excitation to address the paper's autofluorescence, for detecting human chorionic 
gonadotropin (hCG) on LFA strip: a smartphone's flash is turned on for short excitation; b flash 
is turned off showing luminescence imaging 
 
Autofluorescence indexing 
Up until now, what has been discussed are methods to avoid, normalize, or subtract the 
inherent autofluorescence of paper matrices. In a recent publication from Shah and Yager [118], 
a systematic “autofluorescence index” was proposed using excitation-emission matrices for 
screening and selecting paper substrates for low autofluorescence when developing assays. 
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Conventionally, primarily and solely spectral overlap is considered between target-induced 
fluorescence and paper overfluorescence. In Shah and Yager’s study, 12 common-used paper 
matrices, including nitrocellulose, glass fiber, and cellulose, were evaluated using the developed 
autofluorescence index equations. The proposed quantification of autofluorescence was further 
investigated and demonstrated using a quantum dot lateral flow immunoassay for detection of 
influenza A nucleoprotein. It was concluded that paper matrices with lower calculated 
autofluorescence indices had lower limits of detections. 
Use of NIR  
Autofluorescence of paper can also be avoided by using longer excitation wavelengths, 
e.g. near infrared (NIR) or infrared (IR) [119–122]. Yu and White [123] observed that 
background autofluorescence of paper was reduced using 785 nm excitation in assaying 
Rhodamine6G, organophosphate malathion, heroin, and cocaine from a surface-enhanced Raman 
spectroscopy dipstick swab. Similarly, Ju et al. [124] found using longer IR or NIR wavelengths 
as the excitation source reduced autofluorescence as well as undesired back scattering. Their 
paper-based platform utilizing lanthanide-doped LiYF4 upconversion nanoparticles demonstrated 
a limit of detection of 3.6 fmol of DNA. Doughan et al. [125] used a 980 nm NIR excitation to 
reduce background noise that usually corresponds with UV or visible wavelength excitation.  
Smartphone-based optical sensing of fluorescence emission is of recent development and 
has shown numerous technical and physical limitations, especially on paper platforms. However, 
recent implementation of filters, advanced image processing, and unique platform development 
show improved results to better address such challenges. Hopefully in the near future, the 
benefits of contact CMOS imagers could be incorporated into smartphone-based fluorescence 
sensing on paper-based platforms. 
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OVERVIEW OF DISSERTATION 
Standard diagnostic tools used from patient samples, specifically from blood draws, 
require specialized equipment, personnel, and facilities. Conventional techniques can often be 
very laborious and time consuming due to required sample preparation. The evident delay from 
sample collection to a patient’s result immensely impacts their outcome. The aims of this 
research are to design diagnostic biosensors that decrease time-to-results, minimize reagent and 
sample handling, and incorporate automated simple optical transduction and user interfaces for 
the detection of blood-derived biomarkers. Specifically, four biosensing detection mechanisms 
performed on 3 different point-of-care platforms will be discussed.  
First is a static loop-mediated isothermal amplification (LAMP) of nucleic acid aqueous 
droplet on a silicone chip platform immersed in mineral oil. The target-of-interest is a nucleic 
acid sequence as a biomarker for antibiotic resistant bacteria, rfbE gene in Escherichia coli 
O157:H7. The biosensing technique used related changes in interfacial tension (IFT) at the 
water-oil interface by measuring the change in contact angle (geometrical-effects) over time. 
Contact angle, the angle between the plane and the curvature of the droplet, can be directly 
correlated to the energy vector adjacent to the liquid-vapor phase via Young’s Equation. Contact 
angle is a conventional method to determine surface characteristics such as hydrophobicity and 
hydrophilicity. Initially the system was characterized as a linear response in relation to 
concentration of bacteria in a buffer system down to the limit of detection (LOD) of 100 CFU 
per µL. Subsequently, with the addition of bacterial infected blood sample models, the system 
became a binary assay (i.e. yes or no) as low as 10 CFU per µL within 10 min of reaction. The 
major difference between the two systems is the utilization of blood. Blood is complex matrix, 
which means numerous proteins are present that compete with the available surface area at the 
water-oil interface due to preferential adsorption. Overall, time-to-results were as fast as 5 min, 
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being within the window of time for physicians to prescribe adequate treatment for blood stream 
infection diagnosis.  
Secondly, a two-layered, paper microfluidic chip was utilized to quantify cancer cells 
from a buffy coat sample matrix by two detection mechanisms: 1st layer (capture layer) on-chip 
particle enumeration via smartphone microscope and 2nd layer (flow layer) capillary flow 
dynamics via smartphone video processing. On-chip whole cancer cell enumerations were 
validated via benchtop fluorescence microscopy and smartphone florescence microscopy. On 
both benchtop and smartphone fluorescence microscope methods, number of particles in field of 
view (FOV) for 1, 10, and 100 cells per µL were statistically different in comparison to no-
target-control (NTC) samples. Flow rate analysis to quantify antigen/cell fragment concentration 
detected significant signals for 0.1 to 100 cells per µL within the first 6 s of assay. To validate 
flow detection mechanism, a modified Lucas-Washburn (L-W) model was investigated and 
applied utilizing measured viscosity and interfacial tension. Empirical data and L-W model 
showed great alignment with flow velocities between 13 and 22s after sample loading. Proposed 
device and assay platform is able to capture and on-chip image cancer cells within a complex 
sample matrix (buffy coat) while simultaneously quantifying cell concentration in a point-of-care 
manner. 
Lastly, the same concepts previously described in the first platform utilizes changes in 
IFT due to amplicon presence in an aqueous solution immersed in mineral oil. An emulsion 
LAMP platform was investigated to determine the relation between angle-dependent light scatter 
intensity (based off Mie scatter theory) and nucleic acid amplification progression. Again, the 
target gene-of-interst is a biomarker for antibiotic resistnace, specifically rfbE gene in 
Escherichia coli O157:H7. The phenomenon attributing to changes in light scatter intensities is 
due to the interfacial changes occurring in the emulsion droplets, where amplicon amount 
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increases the IFT decreases, resulting in smaller diameter emulsions. Via spectrophotometers and 
fiber optic cables placed at 30° and 60° light scatter intensity was monitored. Light scatter 
intensities collected at 3 min, 30° was able to statistically differentiate 103 and 106 copies per µL 
initial concentrations in comparison to NTC (0 copies per µL). Similarly, 3 min light scatter 
intensities collected at 60° were able to statistically differentiate 106 per µL initial concentrations 
in comparison to NTC. Furthermore, control experiments were conducted to validate nucleic acid 
detection versus protein adsorption and found 30° light scatter intensity can be used to quantify 
protein adsorption (bacteria concentration), while 60° light scatter intensity can be used to 
quantify nucleic acid presence. A smartphone, blinking LED set up was designed and fabricated 
to mirror previous spectrophotometer set up to demonstrate a user-friendly and field-deployable 
platform. Light scatter trends via time lapsed images in correspondence to angle-specific LED 
blinking were comparable to spectrophotometer set up. These four detection mechanisms and 
three platforms offer but a few alternatives as biosensing methods for blood-derived diagnostic 
biosensors.  
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Abstract 
Background. Bacterial infection is a widespread problem in humans that can potentially lead to 
hospitalization and morbidity. The largest obstacle for physicians/clinicians is the time delay in 
accurately identifying infectious bacteria, especially their sub-species, in order to adequately 
treat and diagnose such infected patients. Loop-mediated amplification (LAMP) is a nucleic acid 
amplification method that has been widely used in diagnostic applications due to its simplicity of 
constant temperature, use of up to 4 to 6 primers (rendering it highly specific), and capability of 
amplifying low copies of target sequences. Use of interfacial effect-based monitoring is expected 
to dramatically shorten the time-to-results of nucleic acid amplification techniques.  In this work, 
we developed a LAMP-based point-of-care platform for detection of bacterial infection, utilizing 
smartphone measurement of contact angle from oil-immersed droplet LAMP reactions. Whole 
bacteria (Escherichia coli O157:H7) were assayed in buffer as well as 5% diluted human whole 
blood. 
 
Results. Monitoring of droplet LAMP reactions was demonstrated in a three-compartment, 
isothermal proportional-integrated-derived (PID)-controlled chip. Smartphone-captured images 
of droplet LAMP reactions, and their contact angles, were evaluated. Contact angle decreased 
substantially upon target amplification in both buffer and whole blood samples. In comparison, 
no-target control (NTC) droplets remained stable throughout the 30 min isothermal reactions. 
These results were explained by the pre-adsorption of plasma proteins to an oil-water interface 
(lowering contact angle), followed by time-dependent amplicon formation and their preferential 
adsorption to the plasma protein-occupied oil-water interface.  
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Conclusion. Time-to-results was as fast as 5 min, allowing physicians to quickly make their 
decision for infected patients. The developed assay demonstrated quantification of bacteria 
concentration, with a limit-of-detection at 102 CFU/µL for buffer samples, and binary target or 
no-target identification with a limit-of-detection at 10 CFU/µL for 5% diluted whole blood 
samples.  
 
Introduction  
Bacterial infection is a widespread and common problem that can lead to various complications 
in humans. Specifically, the existence of antibiotic resistant bacteria1 can lead to additional 
complications, including hospitalization and mortality. These bacteria include Staphylococcus 
aureus and Escherichia coli (specifically Shiga-toxin producing type such as O157:H7).2 
Diagnosis of such bacterial infection have traditionally been made based on the patient’s 
symptoms, followed by broad-spectrum antibiotic treatments3, which have shown positive results 
in decreasing mortality rates. However, efforts to conduct such diagnoses in a specific and 
sensitive manner are in high demand. Most importantly, there exist a strong need for identifying 
antibiotic and drug resistant microbes, monitoring the spread of epidemic to pandemic infectious 
diseases, and addressing sociopolitical infrastructure disparities4. 
 The largest obstacle for physician/clinicians is the time delay in accurately identifying 
infectious pathogenic bacteria (especially their sub-species) in order to adequately treat the 
infected patients. Early detection and subsequent adequate treatment are highly correlated to 
decreased mortality and hospitalization5-7. The current gold standard is bacterial identification 
through culture-enrichment processes from patient’s specimens (urine, nasal swab, throat swab, 
blood, serum, tissue biopsy, etc.). Typically, laboratories are equipped with automated culturing 
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systems, where growth curves in enriched media are monitored via carbon dioxide levels, 
fluorescence, or colorimetric photometry. The greatest disadvantage to such conventional 
methods of bacterial identification is their inherently long processing time of about 12 to 72 h. 
Such delays to pathogen identification have been a key obstacle in the early diagnosis and 
administration of treatment for infected patients. Other pitfalls to bacterial cultures for pathogen 
identification are the requirement of specialized equipment, personnel, and facilities5,8. 
 Recent attempts to decrease time-to-results for bacterial identification include the 
integration of molecular diagnostic techniques such as hybridization [i.e. fluorescent in situ 
hybridization (FISH)], nucleic acid amplification [i.e. broad range and multiplexed polymerase 
chain reaction (PCR)], mass spectroscopy [i.e. matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS)], and protein analysis9. By using such molecular 
techniques, the time-to-results is expedited since blood samples can be directly analyzed, 
bypassing the culture-enrichment process. PCR techniques have been more broadly applied in 
blood borne pathogen detection. However, PCR has been notoriously known for its susceptibility 
to false negatives due to the overwhelming background human DNA present in whole blood 
samples. Other components in the specimen such as ions and proteins can also inhibit the 
amplification mechanism8,10. More importantly, PCR requires three set temperatures 
(denaturation, annealing, and extension) that are alternated for ~30 cycles. This necessitates a 
thermal cycler, which is not appropriate for point-of-care (POC) diagnostics. 
 Isothermal nucleic acid amplification technologies have emerged as an alternative to PCR 
techniques, where the amplicons are exponentially produced at a constant temperature11. 
Isothermal techniques have been popularly applied in POC systems due to the requirement of 
only one temperature and the rapid amplification results (as fast as 20 min), making them 
attractive for use in field and clinical settings. A specific isothermal method that has gained 
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much reprise, and is even available in commercial kits for identification of pathogens, is loop-
mediated isothermal amplification (LAMP). The reaction utilizes 4 to 6 primers, rendering it 
highly specific and capable of amplifying low initial copies of target sequence in a sample. 
LAMP amplicons are produced by cycling strand displacements and are dumbbell or cauliflower 
shaped12,13. 
 In the past decade, 146 total publications have been identified using LAMP as a 
molecular diagnostic technique in POC platforms (Web of Science, using the keywords “loop-
mediated amplification,” “diagnosis,” and “point-of-care”). Various detection methods were used 
with these POC LAMP platforms for confirmation and monitoring of target amplification, 
including electrochemical14,15, fluorescent16,17, colorimetric18-20, and turbidimetric (due to 
magnesium pyrophosphate precipitation)21,22 detection. While these detection methods have been 
used for demonstrating LAMP in POC platforms, they are susceptible to many different 
experimental and/or environmental conditions, such as ambient lighting, contaminants in 
samples, etc. They also require rather complicated equipment, such as spectrophotometers, 
optical filter(s), diffraction gratings, and/or noise filtration circuits. 
An alternative detection method is interfacial tension measurement, where droplet height 
or shape is measured as an indicator of amplification. In fact, interfacial tension has been 
measured occasionally for droplet or digital PCR (dPCR), to assure droplets (microreactors) are 
reproducibly formed and maintained with consistent shape and surface energy, especially for 
high-throughput screening procedures23-25. Similarly, due to increased interest in POC 
applications, digital LAMP (dLAMP) platforms have been developed26-28. However, none of 
these studies have actively utilized interfacial tension as a sensing mechanism for the 
amplification of target genes29,30. It is possible to relate this interfacial tension to molecular self-
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assembly at the interface (e.g. water-oil) and protein adsorption/kinetics towards the interface31-
35, and eventually to the quantification of amplified products. 
In this work, a LAMP-based POC platform is proposed for identifying bacterial infection. 
It monitors the changes in interfacial tension, as represented by change in contact angle, of an 
oil-immersed droplet that contains LAMP reaction mixture, utilizing smartphone-based image 
processing. Whole bacteria (Escherichia coli O157:H7 with Staphylococcus aureus as cross-
reference) are assayed. Experiments were repeated with diluted human whole blood as a model 
for human specimen. Specifically, target genes associated with antibiotic resistance are 
amplified: rfbE gene in E. coli and spA gene in S. aureus. Contact angle measurements are 
conducted for the LAMP droplets with and without target presence sitting on a proportional-
integral-derivative (PID)-controlled heater within a disposable polydimethylsiloxane (PDMS)-
based platform. An assay time of < 15 min or as fast as 5-10 min is desired, in order to not delay 
the physician’s decision time in infected patients. Low limit of detection (LOD) is also preferred, 
e.g., as low as 10 CFU/µL sample.  
Methods 
Bacterial samples. Escherichia coli O157:H7 (part #0801622; ZeptoMetrix) and methicillin-
sensitive Staphylococcus aureus (MSSA; part #0801675; ZeptoMetrix Corp., Buffalo, NY, USA) 
samples were cultured in lysogeny broth (LB) Miller’s formula (Molecular Biological 
International Inc., Irvine, CA, USA) at 37°C for 8 hours. 1 mL of final concentrated bacterial 
stocks (105 CFU/µL) were centrifuged at 5.6 g for 10 min and resuspended in 1 mL of nuclease-
free water. Stock bacterial samples were then serially diluted from 108 CFU/mL (= 105 CFU/µL) 
stock to 102 CFU/mL (= 0.1 CFU/µL) in nuclease-free water.  
 
  68 
LAMP reaction mixture. LAMP primers were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) following literature36,37. 10X target-specific primer sets as shown in Table 1 were 
formulated to contain 16 µM each of FIP and BIP primers, 8 µM each of Loop-F and Loop-B 
primers, and 2 µM of F3 and B3 primers. OmniAmp™ RNA and DNA LAMP Kit (Lucigen 
Corp., Middleton, WI, USA) was used. Final mixtures were comprised of 1X reaction buffer, 8 
mM MgSO4, 150 mM betaine, 0.5X primers, 3X OmniAmp polymerase, 8 mM dNTPs (25 mM 
each), 1 µL of target bacteria solution, and 0.01% w/v Span® 80 (S6760; Sigma). LAMP 
reactions were prepared on ice. Samples were amplified conventionally in a PCR tube with 
mineral oil (M5904; Sigma) to avoid evaporation from heat produced. Thermocycler (MJ 
Research, Waltham, MA, USA) was programmed at 69°C for 30 min, followed by refrigeration 
at 4°C. For reactions containing whole blood, 50% v/v of nuclease free water in 1 µL target 
bacteria solution was replaced with 5% v/v whole blood diluted in Plasma-Lyte A (pH 7.4; 
Baxter, Deerfield, IL, USA). Whole blood was stored refrigerated in a VACUETTE® Blood 
Collection Tube with 9NC coagulation sodium citrate 3.2% w/v (454334; Greiner Bio-One 
International, Monroe, NC, USA).  
 
Gel electrophoresis. LAMP products were analyzed using gel electrophoresis. 1% w/v agarose 
gel (A0169; Sigma) in 1X tris-acetate-EDTA (TAE) buffer (35100131; Quality Biological Inc., 
Gaithersburg, MD, USA) was prepared and placed at 120 V for 50 min with an electrophoresis 
power supply (FB200; Fischer Scientific, Inc., Pittsburgh, PA, USA). TrackIt™ 100 bp DNA 
ladder (10488058; Invitrogen, Waltham, MA, USA) was used as a standard for fragment sizing. 
Gels were stained with ethidium bromide (E1510; Sigma) and imaged under UV light. Gel 
images were analyzed using ImageJ software (U.S. National Institutes of Health). 
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PDMS chip fabrication. Custom acrylonitrile butadiene styrene (ABS) resin mold was 3D-
printed using MakerBot Replicator Z18 (MakerBot Industries, Brooklyn, NY, USA) resulting in 
a box shape of 0.5 mm x 0.5 mm x 1 mm, to create a chamber for conducting droplet-based 
LAMP reaction. This mold was then adhered to a two-compartment polystyrene Petri dish (99 
mm x 15 mm; AB1471; Flinn Scientific, Batavia, IL, USA), resulting in the chip template (one-
chamber version depicted in Figure 2 and two-chamber version depicted in Figure 5).  Molds 
were carefully aligned to be parallel to partition for transparent optical window. Sylgard® 184 
Silicone Elastomer Clear (4019862; Dow Corning, Midland, MI, USA) polydimethylsiloxane 
(PDMS) base and curing agent were combined at a 10:1 ratio and poured into chip template 
salinized by tridecafluoro-1,1,2,2-tetrahydroocyl trichlorosilane (78560-45-9; Gelest Inc., 
Morrisville, PA, USA). Cured PDMS replica was separated from the chip template and bonded 
to a microscope glass slide.  
 
Contact angle monitoring with smartphone. Prior to loading LAMP droplet reactions, mineral 
oil and PDMS chip was pre-heated for 10 min in order to assure a constant 69°C temperature. 
Temperature ramping profile is shown in Supplementary Figure S1.  Through the transparent 
optical window of the PDMS platform, real-time detection of LAMP amplification was achieved 
by monitoring the angle tangential to the droplet with respect to the glass surface, during 
constant applied heat. Images were captured every 30 s for 30 min using the Lapse It application 
(Interactive Universe, USA) and a smartphone camera (Samsung Galaxy S8, Suwon, South 
Korea). All images were loaded to ImageJ software and the contact angle was measured by 
ellipse-fit using the Contact Angle plugin. The absolute change in contact angle was determined 
with respect to contact angles measured at 30 min, 15 min, 10 min, and 5 min. This procedure 
was done in triplicates for E. coli O157:H7 target amplification varying concentrations of 105, 
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103, 102, 10, and 0 (NTC) CFU/µL. An unpaired two-tailed t-test compared the changes in 
droplet height with vs. without target presence (NTC) and cross-reactive samples. Error bars 
represent standard error (n > 3). 
 
Design and fabrication of the portable device. The smartphone holder, heated chip stage, and 
temperature controller housing were designed using SolidWorks software (Dassault Systèmes, 
SolidWorks Corporation, Waltham, MA, USA) and 3D-printed using a Makerbot Replicator Z18 
from acrylonitrile butadiene styrene (ABS) material. The heated chip stage consists of a 
thermoelectric heat pump (TEC1-12706, Hebei Int. Trading Co., Ltd., Shanghai, China) and the 
PDMS platform bound to the microscope glass slide. The heated chip stage is adjustable to the 
length of a microscope slide to allow optimum positioning of the droplet to the smartphone 
camera. The temperature controller housing consists of a proportional-integral-derivative (PID) 
controller (JLD612DC,	LightObject,	Sacramento,	CA,	USA)	and a 36-guage type K thermocouple 
(5TC-TT-K-36-36, Omega Engineering, Norwalk, CT, USA) supported by a thermocouple 
holder that is adjustable perpendicular to the length of a microscope slide. This allowed 
positioning of a thermocouple into a reference water droplet. The PID controller is powered by a 
3 V DC power supply, and continuously monitors the temperature within the reference water 
droplet. The reference temperature is used to regulate electrical output to a temperature control 
circuit38 which includes a relay (G5SB, Omron Electronic Components, Kyoto, Japan). When the 
relay is switched to the “on” position, it allows the thermoelectric heat pump to be powered by a 
9 V DC power supply.	The PID controller was calibrated and programmed to sustain a constant 
temperature of 69°C. All compartments of the PDMS chip were filled with mineral oil and 
heated to steady state temperature before loading the 10 µL LAMP reaction mixture and 
reference NTC droplet. 
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Results  
Conventional LAMP and gel electrophoresis detection. Six 10 µL LAMP reaction mixtures 
with 1 µL, 105 CFU/µL E. coli O157:H7 and six 10 µL no target controls (NTC) were prepared 
as a single experiment set. Identical experiments were also performed with 1 µL, 105 CFU/µL S. 
aureus (MSSA) and NTCs. For each experiment set, the LAMP reaction mixtures were 
conventionally amplified for 5, 10, 15, 20, 25, and 30 min (Figure A-1A). Once incubated for a 
set period of time, reaction mixtures were placed on ice, then put through gel electrophoresis. 
Verified gel of each reaction (0 to 30 min) for target (Figure A-1B) was then completed to 
determine successful or non-successful amplification. Amplification was detected at 30 min for 
both targets.  
 
Figure A-1. (A) Schematic illustration of sequential incubation of 10 µL LAMP reaction 
mixtures with target E. coli O157:H7 (105 CFU/µL) or S. aureus (MSSA; 105 CFU/µL) and NTC 
reactions on conventional heat block for 5, 10, 15, 20, 25, and 30 min. (B-C) Sensitivity of 
conventional heat block and gel electrophoresis of LAMP reaction for the detection of E. coli 
O157:H7 rfbE gene and S. aureus (MSSA) spA gene. Amplifications were identified at 30 min 
for both targets. 
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Table 1. Sequences of oligonucleotide primers used 
Target Primer Sequence (5’-3’) 
Size 
(bp)  
E. coli 
O157:H7 
rfbE gene 
F3 AACAGTCTTGTACAAGTCCA 20 
B3 GGTGCTTTTGATATTTTTCCG 21 
FIP CTCTCTTTCCTCTGCGGTCCGATGTTTTCACACTTATTGGAT 43 
BIP TAAGGAATCACCTTGCAGATAAACTAGTACATTGGCATCGTGT 43 
LoopF CCAGAGTTAAGATTGAT 17 
LoopB CGAAACAAGGCCAGTTTTTTACC 23 
S. aureus 
MSSA 
spA gene  
(Protein 
A) 
F3 AATGACTCTCAAGCTCCAA 19 
B3 CTTTGTTGAAATTGTTGTCAGC 22 
FIP 
GCTCTTCGTTTAAGTTAGGCATGTT-
TGCGCAACAAAATAAGTTCA 
45 
BIP AAGTCTTAAAGACGATCCAAGCC-TTCGGTGCTTGAGATTCG 41 
LoopB AGCACTAACGTTTTAGGTGAAGC 23 
 
Contact angle changes during LAMP. To indirectly measure the interfacial effects of the 
LAMP reaction, droplets were placed in a PDMS chip filled with mineral oil where contact angle 
changes were measured, as depicted in Figure 2. 10 µL LAMP reaction mixtures were prepared 
with 1 µL of 105 or 0 (NTC) CFU/µL E. coli O157:H7 bacteria target or 1 µL of S. aureus 
(MSSA) cross-reactive sample where designated E. coli O157:H7 primer set was used. As shown 
in Supplementary Figure S2, target bacteria E. coli had greater change in contact angle in 
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comparison to the cross-reactive target S. aureus (the primers were designed to target E. coli 
O157:H7 but not S. aureus) and NTC sample throughout the 30 min reaction. 
 
Figure A-2. Schematic of real-time monitoring of contact angle during droplet LAMP reaction 
in a PDMS well (single chamber version), followed by contact angle measurement via ImageJ 
and Contact Angle plugin. Ellipse-fit was used.  
 
Sensitivity analysis in a buffer sample. E. coli bacteria solutions were serially diluted from 105 
to 10 CFU/µL (excluding 104 CFU/µL), which were used as target samples utilizing previously 
stated LAMP droplet mixtures in a PDMS chamber filled with mineral oil. Images of droplets 
were captured every 30 s to monitor change in contact angle throughout the 30 min reaction. In 
Figure 3 the calculated change in contact angle (Δθ = θinitial – θ) at 30, 15, 10, and 5 min is shown 
in relation to the concentration of bacteria. Starting at 5 min (Figure 3C), change in contact angle 
shows a fairly moderate R2 value of 0.826 when fitted to a logarithmic regression. This included 
bacteria concentrations of 0 (NTC), 10, 102, and 103 CFU/µL ranging from contact angle change 
of –0.74° to 5.1°. After 10 and 15 min (Figure 3B and 3C) excluding 105 CFU/µL concentration, 
R2 values were 0.593 and 0.751 respectively when fitted to a logarithmic regression, displaying 
inferior proportionality between Δθ and log bacteria concentration. Δθ ranged from 1.07° to 
7.75° at 10 min, and from 1.91° to 8.88° at 15 min. At 30 min (Figure 3A) a fairly good R2 value 
of 0.882 was reported in correspondence to a logarithmic regression, which included all bacteria 
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concentrations from 0 to 105 CFU/µL. Overall, the shortest time-to-result for significant 
detection was observed for 103 CFU/µL bacteria concentration, with a detection time as soon as 
the first 5 min of the reaction. At 30 min, statistical difference between target and NTC was seen 
for all concentrations higher than or equal to 102 CFU/µL, which is the limit of detection (LOD) 
of this assay. 
 
Figure A-3. Change in contact angle (Δθ = θinitial – θ) for varying E. coli concentrations from 0 
to 105 CFU/µL measured at 30 min, 15 min, 10 min, and 5 min. Averages of three different 
experiments. Error bars represent standard errors.  * indicates substantial changes from the initial 
contact angles with 95% confidence. 
 
Sensitivity analysis in a blood sample. In this model, E. coli bacteria was serially diluted in 5% 
whole blood from 103 to 10 CFU/µL and used as the 1 µL target volume for the LAMP reaction. 
As each blood sample was different from each other, the resulting contact angle also varied from 
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sample-to-sample. Therefore, it became necessary to monitor the contact angles of target and 
NTC simultaneously and normalize the target’s contact angle with that of NTC. To this end, a 
PID-controlled prototype was designed and assembled to run a contact angle change analysis in a 
custom-made, two chamber version PDMS chip as shown in Figure 4. Again, images were taken 
every 30 s throughout the 30 min LAMP reaction and used to measure contact angle. Prior to 
calculating change in contact angle, all angles were normalized to those of NTC droplets: 
Δθ/θNTC = θinitial/θNTC,initial – θ/θNTC, where positive Δθ/θNTC correlates to decrease in θ/θNTC. This 
was done to take into account the interfacial effects caused by the fast oil-water diffusion and 
adsorption of blood proteins to the oil-water interface. As shown in Supplementary Figure S3, all 
bacteria concentration showed a change in θ/θNTC at each time interval between 5 and 30 min. At 
5 min, 10 and 103 CFU/µL show statistical difference compared to NTC with Δθ/θNTC of 0.085 
and 0.023 respectively (Figure 5D). At 10 min, all bacteria concentrations from 10 to 103 
CFU/µL showed statistical difference to NTC with Δθ/θNTC of 0.10, 0.11, and 0.088 respectively 
(Figure 5C). Similar to 10 min, 15 min showed statistical difference compared to NTC for all 
bacteria concentrations with Δθ/θNTC ranging from 0.058 to 0.049 (Figure 5B). At 30 min, 
Δθ/θNTC ranged from 0.10 to 0.049 for all bacteria concentrations (Figure 5A). The overall trends 
observed showed a binary logistic, where when target bacteria was present, Δθ/θNTC was 
observed with significant detection as soon as 5 min for 10 CFU/µL and for all bacteria 
concentrations at 10 min.  
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Figure A-4. Fully-integrated, all-in-one PID-controlled device for real-time monitoring of 
contact angle during droplet LAMP reaction in a PDMS-based, two-chamber version chip, for 
side-by-side comparison of target and NTC droplets. 
 
 
Figure A-5. Normalized change in contact angle (Δθ/θNTC = θinitial/θNTC,initial – θ/θNTC) with 
varying concentrations from 0 to 103 CFU/µL in 5% whole blood at 30 min, 15 min, 10 min, and 
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5 min. Averages of three different experiments. Error bars represent standard errors. * indicates 
substantial changes from the initial contact angles with 95% confidence. 
 
Discussion  
Advantages of droplet LAMP. The proposed method and device are well-suited for portable 
and low-cost nucleic acid-based identification of bacterial infection, which is also demonstrated 
in complex sample matrices. In comparison to other nucleic acid amplification devices39-41, the 
developed platform requires neither moving parts nor liquid flow. Within the droplet LAMP 
device, samples and thermocouple components are stationary within their respective reservoirs, 
which reduces the risk for contamination and other factors that can contribute to false assay 
results. Additionally, the contact angle measurement of a droplet is less susceptible to external 
forces and vibrations. Interfacial tension has most commonly been measured via pendant droplet 
analysis, which is quite vulnerable to external vibration and gas entrapments within the needle 
tip; furthermore, it is difficult to deliver uniform heat to the droplet itself due to the presence of a 
needle. 
 The proposed method occurs at an isothermal temperature. Comparatively, PCR-based 
point-of-care devices require large temperature gradients: 94°C for denaturation, 72°C for 
extension, and 50-65°C for annealing. Such broad temperature ranges must also be timed 
precisely to prevent undesirable, non-specific annealing and extension42,43, requiring close 
supervision. As mentioned previously, the droplet LAMP device has an integrated PID 
controller, automatic image capturing, and analysis system. Such integration allows for minimal 
supervision during reaction period and fast contact angle analysis, allowing successful 
identification of target bacterial presence. 
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Challenges in reproducibility. Challenges in droplet LAMP with regards to reproducibility lie 
greatly within the variations between assays. An example of a condition that is varied each run is 
the methodology in which the sample is applied into the chip wells. Aqueous droplet LAMP 
reagent is manually extruded from a blunt end needle tip and placed into the well till gravity 
drops the solution onto the bottom surface. The speed, height, and forces controlled by the user is 
varied between each assay and should be mitigated in the next version of the platform. An 
automated droplet mechanism such as a microfluidic chip or automated pipette could be added to 
control droplet formation and application into chip wells. Incorporation of such techniques will 
help to reduce errors in the device.  
Another variation introduced throughout these experiments is the sample composition 
itself. Blood samples are pooled healthy donor blood that have been diluted to 5 v/v%. In clinical 
settings, this sample matrix is not synonymous. The pooled blood was used to showcase an 
“average” representative sample with numerous variable introduced. With these parameters 
considered, statistical significance was still achieved in comparison to no-target-control samples, 
thus demonstrating promising robustness. However, the assay will still need to be demonstrated 
with extensive trials performed with non-pooled single donor blood to demonstrate statistical 
power and clinical relevance as future work. It is important to increase the number of assays 
done with different sample types to characterize repeatability. Up until now, reproducibility was 
characterized as indicated by standard error bars in graphs.  
 
Assay performance. The change in contact angle of LAMP droplets without blood (buffer 
system) had a logarithmic regression fitted to the bacteria concentration at 30, 15, 10, and 5 min. 
Relatively good R2 values were found at 5 min from 1 to 103 CFU/µL and at 30 min from 1 to 
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105 CFU/µL.  A significant difference was determined in as soon as 5 min for the buffer system 
with 103 CFU/µL bacteria concentration, which was the limit of detection (LOD) at 5 min. LOD 
was reduced to 102 CFU/µL at 15 min and at 30 min. The contact angle analysis of LAMP 
reactions in a blood sample was determined to be a binary assay, i.e., target or no target presence. 
This was demonstrated in as fast as the first 5 min of reaction for 10 CFU/µL (LOD). A 
significant difference was identified for all concentrations tested, from 10 to 103 CFU/µL as early 
as 10 min. Given the small sample volume of 1 µL, the LOD of 10 CFU/µL is close to the lowest 
possible level of detection, despite the presence of whole blood components. The LODs of many 
commercial rapid kits for bacterial infection are typically in the range of 105 – 106 CFU/mL (= 
102 – 103 CFU/µL), which have frequently been used to identify urinary tract infection (UTI) 
from urine44, gonorrhea from urine44, and Streptococcus from throat swab45. Typical 
concentrations of commensal bacteria on human skin can be as high as 105 CFU/cm2, and they 
increase to 107 – 108 CFU/cm2 with symptomatic skin and would infections46. Overall, the 
prototype device demonstrated that the presence of bacteria could easily be identified by 
monitoring the change in contact angle for target and NTC droplets side-by-side, i.e., paired 
comparison. Compared to other conventional quantitative LAMP assays, our method showed 
much shorter assay times. Only a relatively small number of amplified molecules are necessary 
to diffuse towards the oil-water interface to alter the interfacial tension, and subsequently contact 
angle, thus making it a fast time-to-result assay.  
 
Molecular diffusion and adsorption of LAMP amplicons to oil-water interface. As 
illustrated in Figure 6A, nucleic acid amplification occurs inside of the droplet, followed by the 
sequential adsorption of produced amplicons to the oil-water interface due to their (loop-shaped) 
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complex geometry, which compromises solvation in water. The movement of the amplicons, 
especially ones with higher molecular weights, is driven by molecular diffusion. Diffusion 
constants of nucleic acids have been well studied in relation to their size, due to the wide use of 
electrophoresis techniques for size separation. Models such as the Nernst/Stokes-Einstein 
equation, Zimm’s theory, and Kratky-Porod equation have been widely applied47,48 to simulate 
both translational and rotational diffusion of both small rod-like and polymeric chain nucleic 
acid structures ranging from 30 to 5000 base pairs (bp). Generally, such investigations concluded 
that the diffusion coefficient and overall velocity are inversely related to bp length. Products of 
isothermal loop-mediated amplification are large dumbbell-like structures with a wide range of 
bp lengths. Diffusion of such high molecular weight molecules is difficult and slow, especially 
when their concentration is very high (molecular crowding).  
 Both PCR and LAMP amplicons consist of double stranded DNA, which is partially 
hydrophilic due to its sugar-phosphate backbone49. Its interior is more hydrophobic allowing the 
backbone to be held together by van der Waals forces, leading to overall stability of the 
structure50,51. Therefore, amplicons’ surfaces are less hydrophilic (or become relatively 
hydrophobic). Such amphiphilic character is more pronounced with LAMP amplicons due to 
their complex geometry, making them to be excluded in polar solvents and concentrated at the 
oil-water interface due to the hydrophobic effect. This is also similarly observed for another type 
of amphiphilic molecule: proteins52. 
To model amplicon diffusion within a LAMP droplet, a combined exponential growth 
and Fick’s diffusion-based model was used varying initial E. coli bacteria concentration. The 
model takes into account the exponential production of amplicons and the corresponding 
diffusivity constant based on the amplicon’s molecular weight. The model assumes a hemi-
spherical droplet shape (as the initial contact angle is close to 90° in most cases) to determine the 
  81 
maximum number of available spaces for amplicons at the oil-water interface (calculated by 
hydrodynamic radii53,54). The model varies the initial bacteria target concentration (C0, CFU/µL) 
to determine the interface concentration of amplicons (n, amplicons per cm2) at the given time t. 
An amplicon length of 965 bp was used in the simulation in Figure 6A, where 965 bp is 5 times 
the length of target gene, 193 bp (rfbE gene from E. coli). Amplicon length of 1930 bp (10 times 
the target gene length) was also modeled (Supplementary Figure S4). Exponential growth 
constant (k, s-1) and diffusivity constant (D, cm2 s-1) of produced amplicons were chosen based 
on literature55,56 (specific values used can be found in Supplementary Tables S1 and S2). 
Cumulatively, the model determines n with respect to time, t: 
! " = 2%&'() *)+    (1) 
Similarly, to explain and simulate the diffusion and adsorption of blood proteins 
(albumin, IgG, and fibrinogen57) in a blood sample, a Fick’s diffusion equation was utilized.  
    ! " = 2%& '()     (2) 
Using the equations (1) and (2), the % fractions of surface area occupied by amplicons and blood 
proteins were determined using the amplicons’ or blood proteins’ hydrodynamic radii. 
As illustrated in Figure 6A, LAMP droplets (buffer system) with target presence 
internally produce amplicons, which then diffuse and adsorb to the oil-water interface reducing 
interfacial tension, thus changing the droplet contact angle (Figure 3). It was also shown that 
greater contact angle change was observed with increasing initial bacteria concentration. In 
comparison, change in droplet contact angle remained relatively constant in the LAMP droplets 
with no target presence and with cross-reactive target. As shown in Figure 6B and 
Supplementary Figure S4, the slopes of all curves are quite steep, indicating rapid diffusion and 
adsorption of amplicons to the oil-water interface. The time for amplicon saturation is, therefore, 
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dictated primarily by the production rate of amplicons, which is a function of initial bacteria 
concentration. This allows the proposed method to quantify the initial bacteria concentration. 
 
Figure A-6. (A) Illustration and simulation of % surface area occupied by the diffusion of 965-
bp amplicon to the oil-water interface with doubling time of 28.1 s and growth constant k of 
0.022 for initial bacteria concentrations from 105 to 10 CFU/µL in buffer system (without blood). 
(B) Illustration and simulation of % surface area occupied by the diffusion of blood protein 
species (albumin, IgG, and fibrinogen) to the oil-water interface, depicting slower interface 
occupation by blood proteins than those by amplicons while leaving substantial unoccupied area 
that can accommodate amplicons. 
 
With blood present for the blood sample, the trend in contact angle change was binary, 
i.e., target or no target presence. In this model, both amplicons and blood proteins are competing 
for the available spaces at the oil-water interface. With NTC (= 0 CFU/µL, i.e. no amplicon 
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presence), the surface is occupied only by blood proteins, which is a relatively slow process that 
is unable to saturate the entire surface – it takes 7 min to reach maximum surface coverage of 
approximately 60% (Figure 6B). Proteins are unable to saturate the whole surface due to 1) 
spreading and flattening at the interface, 2) lateral repulsion between proteins with net positive or 
net negative charge, especially albumin55, and 3) solvation of proteins that may interfere with 
additional protein adsorption. The remaining 40% of the interface is left for amplicons to arrive. 
However, there are not enough amplicons produced by this time (7 min) for the range of 
concentrations tested (10 – 105 CFU/µL) as shown in Figure 6A and Supplementary Figure S4. 
Therefore, amplicon adsorption is occurring after the surface is occupied with blood proteins. 
This delayed adsorption of the amplicons and competition with the blood proteins is illustrated in 
Figure 6B. While the additional amplicon adsorption did result in further contact angle change as 
shown in Figure 5, its competition with blood proteins rendered this method unable to quantify 
initial bacteria concentration in a blood sample. Despite this, the model successfully identified 
the presence of bacteria in as little as 5 min with as low as 10 CFU/µL initial concentration, 
which is a significant improvement compared to that in a buffer sample. In addition, the error 
bars are generally much smaller than those in a buffer sample, presumably due to the presence of 
blood proteins at the interface, most notably albumin, which can “passivate” the interface. 
Conclusions  
A droplet LAMP-based POC platform was designed and tested for detecting bacteria (E. 
coli O157:H7) from diluted (5%) whole blood samples, utilizing smartphone-based contact angle 
measurements. Monitoring of droplet contact angle was demonstrated in a disposable, two-
chamber PDMS chip, incorporating a compact, PID temperature controller and a smartphone.  
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Analysis of droplet contact angle in a buffer sample showed decrease in contact angle 
with target presence, with log-linear quantifiable capabilities from 10 to 103 CFU/µL E. coli in as 
little as 5 min and from 10 to 105 CFU/µL by the end of the 30 min reaction. In comparison, 
NTC droplets (zero bacteria concentration) did not show significant change in contact angle 
throughout the 30 min isothermal reaction. Analysis of droplet contact angle in a blood sample 
(bacteria spiked into 5% diluted whole blood) showed, again, decrease in contact angle with 
target presence. However, no bacteria concentration-dependent relationships were 
distinguishable, rendering this method binary (i.e. target or no target) in a blood sample. Binary 
results were determined in as little as 5 min for 10 and 103 CFU/µL E. coli and in 10 min for all 
concentration tested (10 to 103 CFU/µL). Thus, we have demonstrated an assay time of 5-10 
min, sufficiently fast for physicians to make clinical decisions, with low limit of detection as low 
as 10 CFU/µL sample. 
Molecular diffusion and interfacial adsorption models were developed for blood proteins 
as well as exponentially produced amplicons. Due to the higher concentrations of blood proteins 
and smaller number of amplicons early in the assay, interfacial adsorption is initially dominated 
by blood proteins, which are later replaced by exponentially producing amplicons that compete 
with the blood proteins. While the assays with blood samples show only binary assay results, 
they are much more reproducible with smaller error bars, which is a unique advantage of this 
method. In other biosensing methods, whole blood generally compromises the assay 
reproducibility or sensitivity. This proposed method can be further investigated and applied in 
other complex biological matrices such as urine, saliva, other bodily fluids, feces, and soft tissues 
for fast (< 10 min) nucleic acid amplification.  
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Supplementary Figure A-S1. PID Temperature controller temperature characterization with 
tuned parameters to ensure constant 69°C throughout 30 min LAMP reaction (P = 0.1%, I = 12 
sec, and D = 28 sec). 
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Supplementary Figure A-S2. Change in contact angle (Δθ = θinitial – θ) of droplet LAMP 
targeting E. coli O157:H7 105 CFU/µL, cross-reactive sample of S. aureus 105 CFU/µL, and 
NTC.  
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Abstract 
Gold standard diagnosis of hematological cancers require complete white blood cell count, 
followed by flow cytometry with multiple CD markers, and cytology. It requires substantial time 
and specialized training. A dual-layer paper microfluidic chip was developed as a quicker, low-
cost, and field-deployable alternative to detect ROR1+ (receptor tyrosine-like orphan receptor 
one) cancer cells from the undiluted and untreated buffy coat blood samples. The first capture 
layer consisted of a GF/D glass fiber substrate, preloaded with cancer specific anti-ROR1 
conjugated fluorescent particles to its center for cancer cell capture and direct smartphone 
fluorescence imaging. The second flow layer was comprised of a grade 1 cellulose 
chromatography paper with wax-printed four channels for wicking and capillary flow-based 
detection. The flow velocity was used as measure of antigen concentration in the buffy coat 
sample. In this manner, intact cells and their antigens were separated and independently analyzed 
by both imaging and flow velocity analyses. A custom-made smartphone-based fluorescence 
microscope and automated image processing and particle counter software were developed to 
enumerate particles on paper, with the limit of detection of 1 cell/µL. Flow velocity analysis 
showed even greater sensitivity, with the limit of detection of 0.1 cells/µL in the first 6 s of 
assay. Comparison with capillary flow model revealed that great alignment with experimental 
data and greater correlation to viscosity than interfacial tension. Our proposed device is able to 
capture and on-chip image ROR1+ cancer cells within a complex sample matrix (buffy coat) 
while simultaneously quantifying cell concentration in a point-of-care manner. 
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Introduction  
Hematological cancers, cancers derived from the blood, are conventionally diagnosed in a 
manner that is very time consuming, requires expensive equipment, and demands for 
professionally trained personnel [1]. Such processes can be especially tiresome and invasive for 
patients suffering from chronic cancers that require months-worth of blood analysis. For 
example, chronic lymphocytic leukemia (CLL) diagnosis requires the presence of ≥ 5 x 109 B 
lymphocytes/L (= 106 cells/µL) in the peripheral blood, sustained for at least 3 months. The 
clonality of these B lymphocytes are then confirmed by demonstration of immunoglobulin light 
chain restriction via flow cytometry. Following, leukemia cells are also morphologically 
confirmed via a microscope blood smear to appear as small, mature lymphocytes with a narrow 
border of cytoplasm and a dense nucleus lacking discernable nucleoli with partially aggregated 
chromatin [2]. CLL is the most common form of leukemia in adults, accounting for 25% to 30% 
of all leukemia derivatives in the United States [3]. Globally, based off of data collected from 
1990 to 2015, 2 out of 100,000 people (age-standardized) were reported to have CLL [4]. While 
a variety of treatment options are now available, CLL has a low response rate, and assessing the 
prognosis of patients remains difficult [5]. This project addresses the need to develop an 
inexpensive, rapid, and point-of-care (POC) method to identify, quantify, and detect 
hematological cancers, including CLL.  
In recent years, various microfluidic POC assays have been developed for detection of 
hematologic cancer and CLL. Previously investigated microfluidic techniques include gene-
specific amplification via on-chip quantitative reverse transcription polymerase chain reaction 
(qRT-PCR) [6,7], aptamer probe hybridization via electrochemical impedance spectroscopy [8], 
on-chip fluorescence microscopy of immunostained whole cells [9], cell sorting by magnetic 
trapping array and lectin affinity [10], and measurement of cell stiffness [11]. Although each 
  97 
technique has its advantage such as specificity, multiplexing capabilities, label-free, and single-
cell sorting, there are also disadvantages. First, all microfluidic platforms mentioned utilize a 
custom silicone-based chip, whose fabrication process can be complex and expensive, requiring 
special equipment and cleanroom access. Secondly, the use of nucleic acid identification 
techniques such as PCR or apta-sensing requires pre-assay sample preparation (i.e. extraction via 
cell lysis, filtration, etc.) and expensive reagents with shortened storage life, making it 
undesirable for field and POC applications. Lastly, cell sorting techniques with on-chip 
immunofluorescence imaging requires lengthy procedures of cell fixation, immunostaining with 
multiple fluorophores, and access to benchtop fluorescence microscopy. 
Use of paper microfluidic platforms with fluorescence sensing has been demonstrated for 
multiple chemical and biological applications. Advantages of paper microfluidics include: an 
inherent pump-free mechanism via capillary and wicking action, ease and low-cost of 
fabrication, disposability, and increased storage-life of reagents preloaded prior to performing 
assay. Fluorescent nanotechnologies such as quantum dots (QD), fluorescent 
micro/nanoparticles, and nanoclusters have consistently shown superior stability and high 
sensitivity in comparison to traditional fluorescent dyes [12-14]. Additionally, smartphone 
optical sensing was chosen due to its holistic capabilities of being portable, user-friendly 
interface, ability to connect and upload to a network, and on-board processing capability [15]. 
However, as paper is optically opaque and generates a large extent of back scattering noise (from 
its fibrous structure) as well as auto-fluorescence, such detection has always been considered 
challenging. 
In this work, we developed a dual-layer paper microfluidic chip pre-loaded with antibody-
conjugated, fluorescent microparticles. This platform consisted of the top capture layer, allowing 
efficient filtration of the buffy coat samples and capture of the cancer cells, and the bottom flow 
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layer generating capillary flow through paper pores necessary for efficient mixing and 
subsequent antibody-antigen binding. Particle binding to the cancer cells captured on the top 
layer was quantified via smartphone-based on-chip microscopic imaging [16]. Particles were still 
aggregated by cell fragments and antigens in the bottom flow layer, causing changes in the 
capillary flow, which was also quantified via smartphone-based real-time monitoring of flow 
velocity [17]. In this manner, intact cells and their antigens were separated and independently 
analyzed. Through this dual detection, cancer cell concentration was evaluated in the undiluted 
buffy coat samples from healthy donors, dosed with known concentration of cancer cells. Buffy 
coat samples can easily be obtained by phlebotomy, although they still contain substantial 
amount of red blood cells and complex to be directly assayed in a handheld platform with 
satisfactory sensitivity. Through utilizing a novel image processing algorithm for microparticle 
immunoagglutination on paper demonstrated in [16], it is possible to make an extremely 
sensitive detection. Our method also involves a second mechanism of detection via flow velocity 
analysis, which has recently been demonstrated as an emerging alternative detection on paper 
microfluidic platforms [18]. 
The biorecognition element chosen for this assay is an antibody that has a high affinity to the 
receptor, tyrosine-like orphan receptor one (ROR1) protein. ROR1 has been a biomarker with 
increasing interest as a diagnostic tool for cancer, specifically for CLL and B lymphoma cells. 
The ROR1 antigen has been demonstrated in numerous studies, as a highly and specifically 
expressed biomarker for CLL disease expression with respect to normal B cells, normal tissues, 
and normal blood cells from healthy donors [19,20]. Other leukemia’s such as B cell acute 
lymphoblastic leukemia and Harry cell leukemia have also resulted in high expression of the 
ROR1 protein [21]. Unfortunately, ROR1 is not easily expressed in vitro leukemia cell culture 
[22,23]; a substitute model cell should preferably be tested for in vitro assays. In fact, ROR1 is a 
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highly versatile biomarker and is found in other malignant cancers including lung, ovarian, and 
prostate cancer [24,25]. Therefore, for this proof-of-concept technology, we have used ROR1+ 
MDA-MB-231 breast cancer cells as the simulated target cells for this platform. 
Overall, our unique method, which utilizes in situ imaging and flow-based washing, allows 
for fast and easy ROR1+ cancer cell detection to monitor the progression of the disease at the 
point-of-care. This novel assay is also far less expensive and requires much less specialized 
training than any of the current methods. These advantages successfully address the current need 
for simple ROR1+ cancer diagnostic and prognostic applications. 
 
Materials and Methods 
Cell culture and suspension 
Mammary gland/breast adenocarcinoma cell cultures (MDA-MB-231; HTB-26, ATCC; 
Manassas, VA, USA) were grown in HyClone Leibovitz L-15 media with 2.05 mM L-glutamine 
(SH30525.01; GE Healthcare; Maidstone, Kent, UK) supplemented with 10% (v/v) fetal bovine 
serum (FBS; 30-2021; ATCC; Manassas, VA, USA), 0.1% (v/v) of 50 mg/mL gentamycin 
sulfate solution (IB02030; IBI Scientific; Dubuque, IA, USA), and 0.2% (v/v) of 250 µg/mL 
Amphotericin B (GE Healthcare; Maidstone, Kent, UK). Cells were cultured at 37°C (HERAcell 
150i; Cambridge Scientific; Watertown, MA, USA) in 0% CO2 until 80% confluent. After 
reaching 80% confluency, MDA-MB-231 cells were passaged following standard procedures 
[26]. Cells were resuspended, counted via a hemocytometer, diluted in media to 105 cells/mL, 
and stained for 15 min with NucBlue Live ReadyProbes Reagent (R37605; ThermoFisher 
Scientific; USA). Serial dilutions were made by pipette mixing (not by vortexing) to prevent cell 
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fragmentation. Excess dye was removed by centrifugation at 1.3 g for 5 min and resuspended in 
pre-warmed 1X DPBS, back to 102 cells/µL concentration. 
Benchtop fluorescence imaging 
An inverted benchtop fluorescence microscope (Eclipse TS100; Nikon Corp.; Tokyo, 
Japan) was used, equipped with fluorescence filters UV-2E/C and G-2A (A.G. Heinze, Lake 
Forest, CA, USA) and an imaging software (NIS Elements; Nikon Corp.). Greyscale images 
were also taken from each filter cube. Images were then superimposed with pseudo-colors: blue 
for NucBlue-stained cells and red for antibody-particles via ImageJ software (US National 
Institutes of Health; Bethesda, MD, USA). 
 
Antibody conjugation to fluorescent microparticles 
Rabbit polyclonal antibody to receptor-tyrosine-kinase-like orphan receptor 1 (anti-ROR1; 
OABF00363; Aviva Systems Biology; San Diego, CA, USA) was used for ROR1 expression on 
cancer cells. 1 M ethanolamine solution (398136; Sigma-Aldrich; St. Louis, MO, USA) was used 
to generate negative control signals with ROR1-positive cell cultures. Anti-ROR1 and 
ethanolamine were covalently conjugated to highly carboxylated, red, 1-µm diameter, 
fluorescent polystyrene particles (CAF-001UM; Magsphere Inc.; Pasadena, CA, USA) with 
reported 538 nm excitation and 584 nm emission wavelengths. Conjugation to particles were 
done by the following method: 1) particles were washed three times, first with 0.05% Triton-X 
100 washing buffer, followed by deionized water with centrifugation of 8,100 g for 8 min in 
between each washing step; 2) washed particles were incubated with activation buffer [1 mg/mL 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC) in pH 6], 5 mM 2-(N-morpholino) 
ethanesulfonic acid (MES), and 1 M NaOH for 30 min on a rocker at room temperature; 3) 10 
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µL of 1 mg/mL ethanolamine or anti-ROR1 antibody solutions were added to activation buffer 
and particle mixture and placed on a rocker for 2 h at room temperature; 4) 1 M ethanolamine 
buffer was added to quench reaction and placed on a rocker for 30 min at room temperature; 4) 
antibody-particle or ethanolamine-particle suspensions were centrifuged and washed similar to 
step 1, but with added 5 min sonication in between resuspension and centrifugation. Particles 
were stored in deionized water in 3-8°C. This EDAC-based covalent conjugation of antibodies to 
carboxylated polystyrene particles has been well-documented to yield a uniform distribution of 
antibodies on the particle surface [27], since the carboxyl-containing co-monomers repel from 
each other and from hydrophobic main-monomer (styrene). In addition, a total of four batches of 
antibody-conjugated particles were used throughout this work to address the batch-to-batch 
variations. 
Capture layer substrate selection – optimum cell retention and particle relief 
The paper microfluidic chip is comprised of two layers: the first capture layer and the 
second flow layer. Pre- and post-washing steps were evaluated for two types of the capture 
layer’s ability to retain cells after washing and relieve unbound particles. NucBlue-stained cell 
suspension or anti-ROR1/ethanolamine conjugated fluorescent particle suspension was applied 
to 6 mm diameter mechanically-punched paper rounds of GF/D borosilicate microfiber filter 
(1823-047; Whatman GE Healthcare; Maidstone, Kent, UK) or G041 glass fiber conjugate pad 
sheets (Milipore Sigma, Billericia, MA, USA). After a 5 min waiting period, paper rounds were 
flipped and imaged using a fluorescence microscope with the addition of a drop of mineral oil to 
omit undesired scatter off glass fibers. The collected images were evaluated for pre-wash steps. 
Post-wash assay images were taken with the continuation of 100 µL of 0.05% Triton-X 100 
(T8787, 398136; Sigma-Aldrich; St. Louis, MO, USA) washing buffer solution to paper rounds 
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with a 1 in × 1 in (25.4 mm × 25.4 mm) grade 1 chromatography paper (Whatman Grade 1 Chr, 
GE Healthcare, Maidstone, Klent, UK) underneath. After a 5 min waiting period, the paper 
rounds were flipped and imaged with the addition of mineral oil.   
Well plate assay procedure 
6 x 104 MDA-MB-231 cells/mL were seeded into 96-well plates and incubated overnight. 
Cells were prepared for a specificity assay by washing with 1X DPBS twice, fixing with 4% 
paraformaldehyde for 15 min at room temperature, and washing again with 1X DPBS twice. Red 
fluorescent anti-ROR1 particles were then added and incubated for 30 min at room temperature. 
To remove unbound particles, a 0.05% Triton X-100 washing buffer was used to wash cells 
twice. 1X DPBS was then added to wells to prevent drying during imaging. As a control, wells 
with no cells were incubated in media overnight, followed by washing, fixing, and incubating 
with particles under the same conditions of the wells with cells. Four 400X fluorescent images 
were taken for each well, where each image represented one field-of-view (FOV). All particles 
were counted for each FOV and tallied for frequency in occurrence. Particles counts greater than 
16 particles per FOV were omitted due to insufficient washing of unbound particles.  
 
Paper chip design and fabrication 
The microfluidic chip was comprised of two layers. The first layer (capture layer) was 6-mm 
diameter, mechanically punched rounds made out of GF/D or G041 glass fiber substrates, for 
preloading antibody-conjugated particles and initial capturing of whole cancer cells (Figure 1A). 
The second layer (flow layer) was designed using SolidWorks 2015 software (Dassault 
Systèmes, Vélizy-Villacoublay, France) and wax-printed (ColorQube 8580, Xerox, Norwalk, 
CT, USA) on grade 1 chromatography paper for wicking and capillary flow measurements along 
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four channels. The width (2 mm) and length (5 mm) of the four channels on the second flow 
layer was selected from multiple iterations for a 10 µL sample to be distributed amongst the four 
channels evenly and to flow along the channel for measurable distances for the smartphone to 
take a video without magnification or zoom (Figure 1B). After the pattern was printed, chips 
were cut and melted at about 120°C for 5 min to allow for wax to flow into the paper fibers 
creating hydrophobic barriers throughout the depth of the paper.  
Paper chip assay procedure 
10 µL of anti-ROR1 conjugated particles were preloaded to the center of the first capture 
layer of the paper microfluidic chip, followed by drying at room temperature, prior to its binding 
to the second flow layer. Cell suspensions of 102 cells/µL were serially diluted down to 0.1 
cells/µL in 1X buffy coat (SER-BC-SDS, ZenBio, Research Triangle, NC, USA). 10 µL of 
dosed samples were applied to the center of the capture layer with a 1 mL syringe attached with 
an 18-gauge blunt needle tip (outer diameter = 1.27 mm) (Figure 1A). Flow along the four 
channels of the second flow layer of the paper chip was monitored via capturing 30 fps videos 
using a smartphone (Samsung Galaxy S8; Samsung, Suwon, South Korea), without separating 
the capture layer (Figure 1B). Once all channels have been saturated the video was ended and 3 
steps of 30 µL washing buffer was added to the capture layer every 1 min. The capture layer was 
then separated and placed on a microscope stage for particle count analysis (Figure 1C). 
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Figure B-1 (A) Dual-layer paper chip assay procedure with 1) a capture layer (glass fiber), pre-
loaded with red fluorescent, anti-ROR1 conjugated microparticles, 2) a flow layer (wax-printed 
chromatography paper), 3) a buffy coat sample with dosed cancer cells, and 4) a blunt-end 
needle tip syringe for uniform droplet application. (B) A smartphone captures a video for 
monitoring the flow velocity from the flow layer. (C) A smartphone-based fluorescence 
microscope images the capture layer for quantifying ROR1+ cancer cell. (D) Schematic of flow 
based detection with no target (more particles at the flow front, increasing interfacial tension γLG) 
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and with target (more particles not at the flow front due to immunoagglutination, increasing 
viscosity µ). 
Design and assembly of smartphone-based fluorescence microscope device 
Cells captured on the capture layer were imaged with a custom-made smartphone 
fluorescence microscope. A commercially available smartphone microscope (AOMEKIE 
Cellphone Microscope Magnifier; 60X-100X zoom with a UV LED) was modified as follows: 
Firstly, the existing LED was replaced with a 525 nm blue LED (MTE5052M3A-UBG, 
Marktech Optoelectronics, Thief River Falls, MN, USA) for fluorescence excitation of antibody-
conjugated microparticles. Secondly, a 3D-printed attachment (an enclosure and a moveable 
stage) was constructed and added to the microscope to provide a dark enclosure and a moveable 
stage, made out of black acrylonitrile-butadiene-styrene (ABS) polymer using a 3D printer 
(Zortrax M200, Zortax Inc., Olsztyn, Poland). This attachment was designed using SolidWorks. 
Thirdly, the attachment was also designed to incorporate a 589 ± 2 nm optical bandpass filter 
(65-707, Edmund Optics, Barrington, NJ, USA) to capture fluorescence emission from the same 
particles. 
Image processing algorithm – particle count 
Both smartphone and benchtop microscope images were pre-processed and analyzed via 
MATLAB 2019a (MathWorks, Natick, Massachusetts, MA, USA). The pre-processing algorithm 
includes the use of a bandpass noise filter in the Fourier Space to enhance higher frequency 
signals and filter out low frequency signals caused by autofluorescence or undesirable light 
scatter. An optimal binary threshold of 0.6 was then applied, highlighting only the antibody-
conjugated fluorescent particles on paper. A circular object function was then utilized to count 
and augment the measured diameters onto the pre-processed image.  ImageJ 1.51m9 (National 
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Institutes of Health, Bethesda, MD, USA) was also used to analyze benchtop microscope images 
for initial substrate optimization and specificity test.  
Image processing algorithm – flow analysis 
30 fps videos were parsed into 1 s time interval images. Images were processed and analyzed 
via MATLAB. Auto-contrast stretching [24] and chromatic adaptation function [25] were used 
for white balance as well as for the enhancement to better detect buffy coat color. Binary 
thresholds and fill-in functions were also used prior to measure lateral capillary flow distance 
from the edge of the first capture layer. A moving average was then applied to raw 
measurements. Capillary flow velocity was then determined as the slope of the average flow 
distance at 3 different time intervals: Δt1, Δt2, Δt3, and Δt4, which correspond to 2 to 6 s, 7 to 12 
s, 13 to 22 s, and 23 to 32 s. 
Viscosity measurements 
The viscosity of each mixture containing particles and target cells in growth media (L15) was 
measured using oscillatory shear rheology on a Discovery Hybrid Rheometer 2 (TA Instruments, 
New Castle, DE, USA) with a 40 mm diameter and 0.5° cone geometry. Sample mixtures were 
pipetted and spread evenly on a 40 mm stage before lowering the gap height to 30 µm. A Peltier 
temperature-controlled stage maintained samples at 37°C during rheology measurements. A 
shear stress sweep was performed from 0.001 to 100 Pa at a constant 10 rad/s angular frequency. 
The viscosity of particles and cancer cell mixtures from 0 to 100 cells/µL was determined by the 
slope of the shear stress (t) vs. shear strain rate (!  ) plot [26,27]. 
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Interfacial tension measurements 
Interfacial tension (mN/m) was measured with an FTÅ200 contact angle/surface tension 
analyzer (First Ten Ångstroms, Portsmouth, VA, USA) using the pendant droplet method. Five 
10 µL of anti-ROR1 particles with either 100, 10, 1, 0.1, or 0 (NTC) of MDA-MB-231 cells/µL 
were prepared. Particle-cell mixture were then extruded from an 18-gauge blunt needle (outer 
diameter = 1.27 mm) and measured. 
Results and Discussion  
Selection of the capture layer substrate for optimum cell and particle retention 
 
Two different types of capture layer were investigated to determine best ability to retain cells 
and relieve particles after the washing step. Figure 2A shows the average cells or cluster per 
field-of-view (FOV) for MDA-MB-231 breast cancer cells on G041 and GF/D glass fiber 
substrates. Average cells/cluster per FOV were 2.2 for pre-wash and remained the same for post-
wash on G041. In comparison, average cells/cluster per FOV were 4.0 for pre-wash and 2.7 for 
post-wash with GF/D. More cells/clusters were observed with GF/D than G041 and washing was 
more effective with GF/D. Figure 2B illustrates capture layer’s ability to retain or relieve 
particles post-wash. More particles were captured with GF/D than G041, and more particles were 
retained after washing with GF/D than G041. 
In addition, we found that the GF/D produced less undesired background scatter over G041. 
G041 fibers acted as miniature optical fibers that transmitted and propagated the excitation light 
along the fiber itself causing difficulty in distinguishing the fluorescence from the NucBlue-
stained cells or the fluorescent particles. While we did find that such background light scatter 
could be reduced when mineral oil was added. By adding mineral oil to the glass fiber substrate 
for fluorescence imaging we reduced the difference in refractive index between the glass fibers 
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(n = 1.5) and the surrounding media (n = 1.47 for mineral oil vs. n = 1.00 for air). Unfortunately, 
it was not a significant enough reduction method in noise in comparison to the GF/D paper 
substrate. Taken together, GF/D was chosen as the better substrate for the capture layer. 
 
 
Figure B-2. Selection of capture layer substrate for optimum cell retention comparing pre- and 
post-wash of (A) MDA-MB-231 cells and (B) BSA-conjugated particles, on G0401 and GF/D 
glass fiber substrates. Averages of 5 assays. Error bars represent standard errors. 400X 
microscopic overlaid images of (C) pre- and (D) post-wash NucBlue-stained MDA-MB-231 
cells, as well as (E) pre- and (F) post-wash red fluorescent BSA-conjugated particles, both on 
GF/D glass fiber substrates. 
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Verification of specific binding of anti-ROR1 particles to cells via well-plate assays 
MDA-MB-231 ROR1+ cells were seeded onto tissue culture well plates (TCP) and fixed 
with formaldehyde to run specificity tests of antibody-conjugated particles. Anti-ROR1 particles 
were added to wells with and without cells seeded, incubated, and washed. Supplementary 
Figure S1A depicts the frequency tally of randomly chosen FOVs in which the total number of 
particles were counted. As shown, anti-ROR1 particles had a higher frequency with higher 
number of particles in FOVs where MDA-MB-231 cells were present. The highest frequency 
count had 4 FOVs with 8 total particles, followed by 3 FOVs with 12 total particles. In 
comparison, areas with no cells had low frequency FOV counts of 1, however ranging from 0 to 
12 total particles in FOV. Supplementary Figure S1B and S1C are FOVs in which anti-ROR1 is 
specifically binding to MDA-MB-231 cells. It is also observed that anti-ROR1 particles are also 
clustered in areas near, but with no MDA-MB-231. This suggests that although whole cells are 
not present, antigens may be responsible for particle binding and clustering, presumably due to 
the use of a surfactant-based washing buffer as well as the inherent mobility of cells during 
growth. 
On-chip particle counting using a benchtop fluorescence microscope 
A dual-layer paper microfluidic chip was designed and fabricated as shown in Figure 1A. 
The first capture layer is a mechanically punched, 6-mm diameter GF/D glass fiber where the 
cells are loaded and captured. GF/D was selected as the optimal paper substrate in capture and 
retention of cells and particles, as previously discussed. The second flow layer of cellulose 
chromatography paper allowed for wicking of applied sample and washing buffer. Four channels 
were designed and wax-printed to create hydrophobic barriers. 
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Fluorescence imaging was initially conducted for the first capture layer using a benchtop 
fluorescence microscope (Figure 3A). Particle area in FOV was evaluated in relation to varying 
cell concentration in a buffy coat matrix utilizing a custom MATLAB particle analyzer code 
(Figure 3B). Image pre-processing algorithm with Fourier bandpass noise filtering and binary 
thresholding was used prior to measuring particles in FOV (Figure 3C). The Fourier bandpass 
filtration mitigates low frequency and high frequency signals leaving an image in which an 
optimal frequency corresponding to the fluorescence light of the anti-ROR1 particles. This 
leaves an image of varying light intensities, in which a binary threshold is applied to result in 
fluorescence from the particles in a clear format to determine the total pixel area of captured 
particles. ROR1+ cells were serially diluted to 0.1 to 100 cells per/µL in buffy coat. 400X 
images were taken, processed, and measured for area of particles in FOV. The general trend was 
as cell concentration increased, particle area in FOV increased. With 100 cells/µL an average 
particle area of 2264 pixels in FOV was statistically different in comparison to no target control 
(NTC; no cancer cells) with the p value of 1x10-6. Following, 10 cells/µL was also statistically 
different with an average particle area of 1164 pixels in FOV with the p value of 0.007. 
Following, cell concentrations of 1 and 0.1 cells/µL with average particle areas of 132 and 206 
pixels were statistically different from NTC with the p values of 0.023 and 0.001 (Figure 3D). 
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Figure B-3.  (A) On-chip particle counting analysis from the first capture layer of the dual-layer 
paper microfluidic chip using a benchtop fluorescence microscope. (B) MATLAB graphical user 
interface (GUI) for counting particle areas. (C) Raw and processed images: (1) raw 400X image, 
(2) Fourier bandpass filtered image with adjusted brightness and contrast, (3) image after 
grayscale normalization and global threshold binarization, and (4) final image with augmented 
particle detection. (D) Particle area in FOV in relation to dosed ROR1+ cell concentration from 
0.1 to 100 cells/µL. 
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On-chip particle counting using a smartphone-based fluorescence microscope 
The correlation between particles area in FOV and concentration of dosed ROR1+ cancer 
cells in buffy coat was demonstrated utilizing a smartphone-based fluorescence microscope, for 
its application in a more user-friendly and field-deployable manner. As shown in Figure 4A, a 
smartphone microscope was attached to the camera of a smartphone via a phone case and used to 
capture images of fluorescent anti-ROR1 particles on the second flow layer of the dual-layer 
paper microfluidic platform. To filter true signals from noise, especially from the GF/D glass 
fiber substrate, further physical light filtering and image digital processing were utilized. The 
smartphone attachment was comprised of three components: 1) 589 ± 2 nm optical bandpass 
filter that allows only the fluorescence emission from anti-ROR1 particles to the smartphone 
camera, 2) a commercially available smartphone microscope, replaced with a 525 nm LED, 
specific to the excitation wavelength to the anti-ROR1 particles, and 3) 3D printed enclosure and 
user-movable stage that housed the paper microfluidic chip with captured cells and particles. The 
optical bandpass filter mitigates weaker, non-specific fluorescence as well as reducing the 
amount of light. A Fourier bandpass filtering and binary thresholding algorithm (used for the 
benchtop fluorescence images) was also used to quantifying particles in FOV (Figure 4B). The 
MATLAB particle analyzer code and its GUI used for benchtop fluorescence microscopy (Figure 
3B) were also used for smartphone-based fluorescence microscopy, using MATLAB Mobile 
(Supplementary Figure S2A). The operation procedure for final user is also illustrated in 
Supplementary Figure S2B. 
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Figure B-4. (A) On-chip particle counting analysis from the first capture layer of the dual-layer 
paper microfluidic chip using a smartphone-based fluorescence microscope. The smartphone-
based fluorescence microscope is comprised of (1) a smartphone case (180 mm x 80 mm), (2) a 
25-mm diameter, 589 ± 2 nm optical bandpass filter, (3) a commercial smartphone microscope 
attachment, replaced with a 525 nm LED, and (4) a 3D printed enclosure and a moveable stage 
with manual user lever. (B) Raw and processed smartphone images: (1) raw cropped 300X 
image, (2) Fourier bandpass noise filtered image, (3) image after grayscale normalization and 
global threshold binarization with threshold of 0.4, and (4) final image with augmented particle 
detection. (D) Particle areas in FOV in relation to dosed ROR1+ cell concentration from 0.1 to 
100 cells/µL. 
 
ROR1+ cells were serially diluted in buffy coat to obtain cell concentrations of 0.1, 1, 10, 
and 100 cells/µL. 200X images were taken via smartphone-based microscope, processed, and 
measured for particle area in FOV. A similar trend to the benchtop fluorescence microscope was 
observed. With increasing cell concentration, particle area in FOV present increased. At 100 
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cells/µL, an average particle area of 3487 pixels were measured in FOV and was statistically 
different in comparison to no cells (NTC). Similarly, 10 and 1 cells/µL concentration dosed in 
buffy coat were statistically different from NTC with average particle areas in FOV of 2071 and 
1744 pixels. However, 0.1 cells/µL was not statistically different from NTC having an average 
particle area in FOV of 1179 pixels (Figure 4D).  
 
Flow velocity analysis using a smartphone camera 
The second flow layer of the dual-layer microfluidic chip was designed to have four channels 
to wick the sample solution from the center and to quantify antigens and cell fragments not 
captured in the first capture layer. A smartphone captured 30 fps videos during the assay, which 
were parsed into 1 s interval images, color enhanced, and measured for flow distance (Figure 
5A). Antibody-conjugated particles are aggregated upon binding to targets, in this case, mostly 
antigens released from cells or possibly cell fragments, but not the whole cells (ranging from 5 to 
10 µm) as they are mostly captured in the first capture layer and are too big to flow through the 
second flow layer (20 µm). Non-aggregated particles easily adsorb to the liquid-air interface (i.e. 
moving front) within paper fibers due to their relative hydrophobicity, and subsequently lowers 
the interfacial tension. Aggregated particles, however, diffuse to the liquid-air interface 
substantially slower, and the resulting flow velocities (flow distances) should be substantially 
different between non-aggregated and aggregated particles, i.e. between target non-presence and 
presence [14] (see Figure 1C for illustrated flow detection phenomenon). The presence and 
nature of blood components also affects the flow velocity (distance) [32]. 
The flow velocity in which applied sample flows from the loading zone was investigated, 
originating from spontaneous wicking effects of paper in correlation to cancer cell concentration 
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present in buffy coat. Flow velocity was measured at four time-intervals: Δt1, Δt2, Δt3, and Δt4, 
which correlated to 2 to 6 s, 7 to 1 2s, 13 to 22 s, and 23 to 32 s, respectively (Figure 5B). Δt1 
showed the greatest sensitivity and significant differences in flow velocities for all cell 
concentrations in comparison to NTC (no cancer cells) samples. Average flow velocities ranged 
from 2.75 pixels/s at 1 cell/µL and 3.88 pixels/s at 10 cells/µL. Δt2 and Δt3 showed significant 
differences in average flow velocities for all cell concentrations in comparison to NTC samples 
except for 1 cell/µL at Δt2. Average flow velocities ranged from 2.05 pixel/s and 3.57 pixels/s.  
Lastly, Δt4 displayed the least dynamic range and least significant difference in average flow 
velocity to NTC samples. Overall Δt3 time interval flow velocities in correspondence to dosed 
cancer cells in buffy coat showcased the best overall dynamic range, where 100 cells/µL (high 
concentration) delayed signal, was able to be detected. Therefore, Δt3 time interval flow 
velocities were used as the empirical comparison to a capillary fluid dynamic model.  
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Figure B-5. Image processing algorithm for evaluating capillary flow velocites from 
smartphone-acquired videos: (1) Parsed 30 fps video to 1 s image shots; (2) Color balanced 
image to [150, 100, 100] RGB pixel intensities; (3) Extracted green channel image with user-
designated channel crop tool; (4) Cropped, binary, and inverted images of channel of interest, 
from left to right. (B) Capillary flow velocities in relation to dosed buffy coat with cell 
concentration from 0 to 102 cells/µL at four different time intervals: Δt1, Δt2, Δt3, and Δt4, which 
correlated to 2 to 6 s, 7 to 12 s, 13 to 22 s, and 23 to 32 s, respectively. 
 
As seen in Figure 5B the four different panels are the average flow velocities at different 
time intervals after the assay start time, which is after the dosed-cancer cell buffy coat sample is 
applied to the first layer. At ∆"#  and ∆"#  time intervals signals at the highest concentration, 100 
cells per µL, are dropping in comparison to the lower concentrations of 0 to 10 cells per µL, 
  117 
where it is an overall proportional relationship. This can be explained since at higher 
concentrations there are more cells being captured in the first layer, therefore delaying the flow 
antigen detection mechanism at the second layer. As we increase the time in which we observe 
the flow velocity, ∆"#  at 13 to 22s, 100 cells per µL shows a higher flow velocity than in 
preceding lower concentrations. Therefore ∆"#  showed the most dynamic range and was used to 
compare to the modified Lucas-Washburn model. Lastly, ∆"#  shows non-significant increase in 
flow velocity in relation to cell concentration because the signal has been saturated at longer 
periods of time.  
 
Comparison with Lucas-Washburn capillary flow model 
A common and widely used model for capillary flow through paper microfluidics is the 
Lucas-Washburn (L-W) model relating flow distance (l) over time (t) [29]. 
 
l2 / t = (R γLG cos θ) / (2µ)        (1) 
 
As demonstrated in [13], the changes in R (pore size) and θ (contact angle) were negligible 
compared to those in viscosity (µ) and interfacial tension (γLG) upon changing the target 
concentration and particle aggregation. Therefore, we assumed R and θ to be constant and 
measured µ and γLG of 0 to 102 cells/µL cell suspensions with anti-ROR1 particles as input 
parameters into the model. Relative viscosity (µ) was determined from shear stress (!  ) versus 
shear rate (!  ) curves (Supplementary Figure S2) via cone-plate rheology. It should be noted that 
0.1 cells/ µL was mitigated from data set since number of cancer cells in sample volume is too 
low for accurate rheology measurements due to competitive adsorption to surface [26]. It showed 
an inverse relationship with increased cell concentration, with up to a 31% decrease in viscosity 
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at 100 cells/µL (Figure 6A). Relative interfacial tension (γLG) measurements via pendant droplet 
analysis showed no significant trends with increased cell concentration. IFT differed from no cell 
samples by an increased 5% at the maximum concentration of 100 cells/µL (Figure 6B). 
Therefore, the most influential driving force for our system with regards to capillary flow-based 
detection is viscosity.  
Inputting measured viscosity and IFT values to the equation 1 and normalized to that of 0 
cell/µL provided the relative flow rate (l2/t), where the constant R and θ are cancelled out. It 
resulted in an increasing flow as cell concentration increases with up to 34% at 100 cells/µL in 
comparison to no cell samples. Relaying back to the empirical data collected for flow velocities 
with varying cancer cell concentrations in comparison to the L-W modified model, similar trends 
were achieved (comapre Figure 5B: Δt3 = 13 to 22s and Figure 6C). This suggests that particle 
immunoagglutination due to free antigen presence decreases relative viscosity before the moving 
front contributing to less unbound particles at the interface, thus resulting in increased flow. In 
comparison, absence of particle immunoagglutination due to no target presence, allows more free 
particles to quickly move to the moving front increasing the relative flow along the channel 
(Figure 1C). 
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Figure B-6. (A) Relative viscosity (µ) measurements via cone-plate rheology for 0 to 102 
cells/µL cell suspensions with anti-ROR1 particles. (B) Relative interfacial tension (γLG) 
measurements via pendant drop analysis for the same. (C) Relative flow (l2/t) normalized to zero 
cell concentration, calculated with Lucas-Washburn capillary flow model using the parameters 
obtained from A and B. 
 
This viscosity contribution to the flow velocity-based assay may be affected by another 
factor: the viscosity variance of buffy coat blood samples among patients. In a case study [34], 
blood rheology parameters were investigated for red blood cells, white blood cells, and total 
cholesterol levels. Changes in blood viscosity were primarily due to red blood cell related 
factors, but not the white blood cell or cholesterol related factors. Even the variance in red blood 
  120 
cells was marginal when the shear rate is lower than 40 s-1. Therefore, patient variations can 
potentially be neglected when the buffy coat samples are tested.  
Challenges in assay reproducibility 
 
The sample matrix itself was pooled buffy coat purchased from commercial vendors. 
Since pooled blood was used, it is representative of the breadth of variations introduced from 
individual patient samples such as hematocrit concentration (red blood cell concentration), total 
cholesterol, and viscosity. Buffy coat aliquots were initially produced and stored in deep freezer, 
then thawed in a water bath prior to performing assay. This procedure was followed to lower 
variation of sample matrix composition and integrity between assays done on different days.  
 Other variations that may have been taken into consideration, are the variations 
introduced from the ROR1+ cancer cells, MDA-MB-231 breast cancer cells. Initially, 
commercially purchased cell lines were grown to confluency, then stored in a liquid nitrogen 
environment. This process was continued until enough passages were performed to produce 
enough cells for experimentation. Batches that were less than passage 10 were grown, detached, 
and immediately used for assays for ROR1+ cancer cell concentration dosing into buffy coat 
sample matrix. Fresh cells were used to model a more representative clinical sample as well as 
reduce variabilities that could be introduced if using frozen aliquot cells from the same batch 
were used due to degradation during storage. Also, particle synthesis batch to batch variation was 
taken into account via the use of a standard curve. In total four anti-ROR1 conjugation to 
polystyrene particles were synthesized and used for experiments throughout this paper.  
Furthermore, challenges in reproducibility with the CLL dual-layer assay lie within the 
variation of the fabrication of the paper microfluidic assay. Environmental factors such as 
humidity can be a factor to take into account when evaluating the fabrication of paper 
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microfluidic assays. All assays were stored and performed at room temperature under the same 
conditions. However, in future experiments humidity and weather conditions in which the assay 
is being performed should be noted to determine if meaningful trends are attributed to 
environmental factors.  
Other factors revolving around the paper microfluidic fabrication’s variability in 
reproducibility is the placement of fibers in relation to the first and second layer. Orientation of 
fibers in relation to the first and second layer were randomly placed at the start of each assay 
during the pre-loading of antibody conjugated particles to first layer. However, it should be noted 
that pore size can be varied solely based on the orientation. For example, if paper fibers were 
parallel versus perpendicular can greatly affect the capturing layer’s retention ability. In future 
work, paper fiber orientation between the first and second layer should be tracked to determine if 
meaningful correlations exist. Overall, we believe that these variables do not majorly contribute 
to errors, since statistical trends were still able to be obtained.  
 
Conclusion  
In summary, we have developed a dual-layer paper microfluidic chip quantifying both whole 
cells captured on-chip through imaging the antibody conjugated fluorescent particles and 
antigen/cell fragment through monitoring capillary flow velocities. This proposed method was 
demonstrated for detecting ROR1+ cancer cells in a complex matrix of buffy coat samples that 
would be similar and relevant for clinical use. The similarity between these two assays also 
suggests that they can be used in a complementary manner in quantifying ROR1+ cancer cells. It 
is a quick and low-cost alternative to detect hematological cancer including chronic lymphocytic 
leukemia (CLL) in comparison to traditional, lengthy, and expensive cell counting 
methodologies and label-specific assays. MATLAB codes and GUIs were developed for on-chip 
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image analysis as well as flow measurement. Direct imaging of particles found in the capture 
layer demonstrated the device’s ability to quantify cell concentration down to 1 cell/µL utilizing 
a smartphone based fluorescent microscope. Flow velocity measurements from parsed and color-
enhanced smartphone videos showed statistical differences from no target samples as early as 6 s 
for the cell concentration down to 0.1 cells/µL. Flow measurements were validated and fitted to a 
Lucas-Washburn (L-W) model that was fed empirically collected relative viscosity and 
interfacial tension measurements. The L-W model fitting suggested that the flow detection 
method for our specific system, was driven by viscosity as most influential parameter 
contributing to increased flow with increased cell concentration. The overall procedure requires 
one pipetting for loading a sample, separation of a dual-layer paper microfluidic chip, and 
acquisition of a video and microscope images, with the assay time less than 10 minutes. This 
device and method can easily be translated and modified for clinical applications as well as other 
targets of interests such as other ROR1+ cancer cells (with high cell load), mammalian, bacterial, 
or plant cell types. 
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Supplementary  
 
  
Supplementary Figure B-S1. A) Frequency tally of total particles in FOV with and without the 
presence of MDA-MB-231. B and C) Light and fluorescent microscope augmented images 
(400X) of fixed MDA-MB-231 cells with Anti-ROR1 red fluorescent particles attached to both 
whole cells and antigens. 
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Supplementary Figure B-S2. Smartphone MATLAB Mobile apps for measuring the capillary 
flow velocities (1) and particle counts (2). Users will pipette the buffy coat blood sample to the 
top capture layer, and captures a video from its top using a smartphone without the microscope 
attachment. The MATLAB app will analyze the flow velocities from four different channels of 
the bottom flow layer at the optimized time window (13 to 22 s). After that, the top capture layer 
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will be separated and placed within the microscope stage. Another MATLAB app will analyze 
the fluorescence microscopic images and provide the particle counts as its output. 
 
 
 
 
Supplementary Figure B-S3. Cone-plate rheology shear stress (𝜏) and strain rate (!  )  
measurements of buffy coat dosed with 0 to 100 cells per µL 
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Abstract 
An emulsion loop-mediated isothermal amplification (LAMP) platform was investigated 
to determine the relation between angle-dependent light scatter intensity (based off Mie scatter 
theory) and nucleic acid amplification progression and concentration dependencies. The 
phenomenon attributing to changes in light scatter intensities is due to the interfacial changes 
occurring in the emulsion droplets, where increasing amplicon adsorption causes a decrease in 
interfacial tension (IFT), resulting in smaller diameter emulsions. Light microscope images 
confirmed there is a 43.6% size difference in emulsion diameters for mixtures with and without 
DNA fragment present. Mie scatter simulations further confirmed that light scatter intensity is 
diameter dependent. Smaller diameter emulsions will have lower intensity values than larger 
diameter emulsions. Using spectrophotometers and fiber optic cables placed at 30° and 60° light 
scatter intensity was monitored. Light scatter intensity profiles collected for 3 min at 30° are able 
to statistically differentiate 103 and 106 copies per µL initial concentrations in comparison to 
NTC (0 copies per µL). Similarly, 3 min light scatter intensities collected at 60° were able to 
statistically differentiate 106 per µL initial concentrations in comparison to NTC. Furthermore, 
control experiments were conducted to validate nucleic acid detection versus protein adsorption 
and found 30° light scatter intensity can be used to quantify protein adsorption (bacteria 
concentration), while 60° light scatter intensity can be used to quantify nucleic acid presence. 
Overall, we have demonstrated the use of angle-dependent light scatter intensity as a means of 
real-time monitoring of an emulsion LAMP platform and fabricated a smartphone-based 
monitoring system that showed similar trends as spectrophotometer light scatter data, thus 
validating the technology for a user-friendly field deployable platform. 
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Introduction  
Nucleic acid amplification is a gold standard tool for the identification of target genes-of-
interest. Polymerase chain reaction (PCR) is the most used nucleic acid amplification technique 
which utilizes cyclic temperatures to denature, anneal, and extend in order to create linear copies 
of the target gene-of-interest in an exponential amount[1]. However, PCR along with other 
traditional nucleic acid amplification techniques can be limited due to the requirement of pre-
processing samples to extract and purify its DNA/RNA. 
In an effort to monitor in real-time the amplification of PCR reactions, quantitative PCR 
(qPCR) is also a widely used technology. Fluorescent intercalating dyes that have high a high 
affinity to nucleic acids by embedding between base pairs are utilized and monitored to get 
exponential curves, such as ethidium bromide and SYBR® Green[2]. Although, such 
intercalating dyes can result in non-specific signals because it is non-specific to specific gene-of-
interest, but all double stranded DNA (dsDNA). To address this problem, fluorescently tagged 
hybridization probes that are complementary oligonucleotide sequences to the target gene-of-
interest can be utilized[3–5]. Such probes result in fluorescent signals that are specific to the 
amplification of the target gene sequence rather than non-specific amplification (i.e. primer 
dimerization). A limitation to fluorescent probes are they are custom-made and expensive.  
Emulsion platforms can be utilized to address the problem of background signals due to 
non-specific amplification. Water-in-oil emulsion protocols are advantageous in nucleic acid 
amplification techniques due to the ability to compartmentalize target-gene-of-interest into 
individual containment units. This allows for an intrinsic separation mechanism of components 
that may inhibit amplification or induce non-specific amplification[6]. Emulsions can be 
especially advantageous due to the intrinsic presence of surfactants and agitation during their 
formation that could be utilized as an alternative method of “extracting” DNA/RNA.  
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Isothermal nucleic acid amplification techniques have gained interest in previous years 
due to the attractiveness of utilizing a single temperature. A constant temperature for nucleic acid 
amplification mitigates the need for specialized equipment such as thermocyclers to finely and 
rapidly adjust temperatures in an intricate manner like in PCR reactions. This aspect has been 
especially appealing for field-deployable, point-of-care platforms, where simplicity is necessary. 
However, it is notoriously known that isothermal nucleic acid amplification techniques are 
susceptible to nonspecific amplification, rendering in less sensitive than PCR methods[7]. 
Alternative methods of measuring nucleic acid amplification can be conducted by 
measuring the interfacial tension changes of the aqueous nucleic acid amplification reaction. 
Harshman et al., utilized a moving droplet-on-a-thermocouple PCR instrumentation to amplify 
targets-of-interest and monitor its progression in real-time by measuring the droplet size. The 
phenomenon attributing such change in droplet size was due to a decrease in the water-oil 
interface, rendering the droplet unstable as amplicon amount increased within[8]. Similarly, a 
droplet loop-mediated isothermal amplification (LAMP) nucleic acid method was utilized for 
monitoring amplification progression via interfacial-effect detection. The platform was 
comprised of a static, aqueous LAMP droplet immersed in mineral oil, in which the change in 
contact angle was monitored over time and related to interfacial tension[9]. In both platforms, 
time-to-results were reduced immensely in comparison to conventional nucleic acid 
amplification techniques and showed significant amplification in complex sample matrices due 
to inhibition relief at the water-oil interface.  
 In this paper, we focus specifically on LAMP in a water-oil emulsion platform to address 
non-specific signals. We also utilize interfacial effect-based monitoring to achieve rapid time-to-
results. The mechanism in which we will monitor in real-time the effects of amplification is 
based on the interfacial changes of micron size emulsions due to amplicon adsorption, followed 
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by emulsion destabilization[10]. Based on Mie scatter theories, which relate angle-dependent 
light scatter intensity in relation to particle size, we can monitor LAMP reactions progression. 
Specifically, rfbe gene in E. coli were amplified via emulsion LAMP at varying concentrations 
of 106, 103, 1, and 0 CFU per µL. Firstly, the proposed detection mechanism was validated with 
spectrophotometers and fiber optic cables. Secondly, a smartphone camera with blinking LED 
set up was used and resulted in similar light scatter intensity measurements and correlation to 
LAMP reaction progression as the spectrophotometer set up. Light scatter intensity showed to 
decrease in relation to amount of initial target concentration within 3 min of emulsion LAMP 
reaction for both detection set ups. Furthermore, control experiments were conducted to validate 
nucleic acid detection versus protein adsorption and found 30° light scatter intensity can be used 
to quantify protein adsorption (bacteria concentration), while 60° light scatter intensity can be 
used to quantify nucleic acid presence. Overall, we have demonstrated the use of angle-
dependent light scatter intensity as a means of real-time monitoring of isothermal nucleic acid 
amplification in a simple and user-friendly platform.  
Materials and Methods 
LAMP reaction: Escherichia coli O157:H7 (part #0801622; ZeptoMetrix) target stock bacterial 
solution was diluted to different concentrations of 106, 103, 1, 0.1, and 0 CFU µL-1 in nuclease 
free water. LAMP primers were used from literature[11] and purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 10X target-specific primer sets were formulated to contain 16 µM each of FIP 
and BIP primers, 8 µM each of Loop-F and Loop-B primers, and 2 µM of F3 and B3 primers. 
LAMP reactions were prepared on iced and utilized the WarmStart® LAMP Kit DNA & RNA 
(E1700; New England Biolabs Inc, Ipswich, MA, USA). Final mixtures were comprised of Bst 
2.0 WarmStart DNA Polymerase and WarmStart RTx Reverse Transcriptase in manufacturer’s 
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optimized LAMP buffer solution. The LAMP final mixture contained 5:1:0.4:1:2.6 ratio of 
Warm Start LAMP 2X master mix, 10X primer mix, target bacteria dilution (or nuclease-free 
water for no target control, NTC), 20 mg/mL bovine serum albumin (B8667; Sigma), and 
nuclease-free water. Conventionally amplified samples were conducted in a thermocycler (MJ 
Research, Waltham, MA, USA) programmed for 65°C for 30 min, followed by refrigeration at 
4°C.  
 
Interfacial tension (IFT) measurements: Interfacial tension (mN m-1) measurements were 
made with an FTÅ200 contact analyzer (First Ten Ångstroms, Portsmouth, VA, USA) using the 
pendant droplet method. Conventionally amplified LAMP reactions with assay times of 0, 5, 10, 
and 15 min were extruded from an 18-gauge blunt needle (outer diameter = 1.27 mm) and 
measured after the pendant droplet had been hanging for 30 s.   
 
Light scatter detection: An incident light of 650 nm (LS-450 LED; Ocean Optics) illuminated 
emulsion samples via fiber optical cable, while 3 fiber optical cables connected to a 
spectrophotometer (USB4000, Ocean Optics) placed at 30°, 60°, and 90° collected light 
intensity. Light scatter intensity measurements were collected every 3s or 1.5s. A 3D printed 
attachment[10] was used to secure optical instrumentation and vial with emulsion reaction 
throughout assay.  
 
Conventionally amplified emulsion light scatter detection and diameter measurement: 10 
µL conventionally amplified LAMP reactions with assay times of 0, 5, 10, and 20 min were 
placed into pre-heated 65°C oil phase with a 650 nm incident light illuminating on sample. At 
the 60° angle, bulk light scatter was collected via fiber optic cable and spectrophotometer. 10 µL 
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of the emulsion was also collected at 1 min, when sufficient emulsion formation was succeeded. 
Microscope images were then post-processed and measured in ImageJ software (US National 
Institutes of Health; Bethesda, MD, USA).  
 
Mie scatter simulations: Mie scattering simulations were performed using MiePlot v4.6 (Phlip 
Laven, www.philiplaven.com/mieplot.htm). The simulation assumed a refractive index of sample 
medium (mineral oil) = 1.47, refractive index of emulsions (water) = 1.33, a 650 nm incident 
light, and particle sizes varying from 9.42 µm to 0.42 µm. Light intensity at 30°, 60°, and 90° 
angles were investigated.   
 
Emulsion LAMP assay: Water-in-oil colloidal emulsions were prepared in a similar fashion as 
a published method[10]. A single emulsion reaction consisted of the addition of a 10 µL aqueous 
LAMP droplet from a blunt end needle tip suspended and dropped uniformly into 2 mL of 
preheated 65°C oil phase. Emulsions were formed and agitated by a micro stir bar set to 1500 
rotations per minute for 30 min. Post-reaction, emulsions were collected and byproducts were 
extracted via 3 iterations of water saturated diethyl ether[12].  
 
End-point amplification analysis of emulsions: Spectroscopy: After emulsions assay was 
performed then broken, the amplicon precipitate dissolved in an aqueous solution was analyzed. 
Presence of nucleic acid was determined by measurement of absorption at 260 nm. Gel 
electrophoresis: LAMP products were analyzed using gel electrophoresis. 3% w/v agarose gel 
(A0169; Sigma) in 1X Tris-acetate-EDTA (TAE) buffer (35100131; Quality Biological Inc, 
Gaithersburg, MD, USA) was prepared and placed at 120 V for 50 min with an electrophoresis 
power supply (Fischer Scientific; FB200). TrackIt™ 100 bp DNA ladder was used as a standard 
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for fragment sizing. Gels were stained with ethidium bromide (E1510; Sigma) and imaged under 
UV light. Gel images were analyzed using ImageJ software (U.S. National Institutes of Health). 
 
Results and Discussion  
Interfacial Tension: Conventionally amplified LAMP reactions with assay times of 0, 5, 10, and 
20 min were used to measure interfacial tension (IFT) with various DNA amounts. 10 µL 
samples were measured for IFT via pendant droplet analysis. As seen in Figure 1A, the overall 
trend is that with increasing amount of DNA fragment mixture there is a decreasing trend in IFT.  
IFT measurements were 39.39 mN/m for 0 min LAMP assay time, 39.16 mN/m for 5 min, 37.28 
mN/m for 10 min, and 36.92 mN/m for 20 min. Essentially, decreasing IFT measurements with 
respect to amount of DNA is quantifying the stability of the droplet. As more DNA is present, 
the overall droplet’s surface tension is destabilizing due to the amplicon adsorption at the outer 
surface area of the hanging pendant droplet. This overarching phenomenon will be used as the 
means in which we justify the detection method in our emulsion platform.  
 
Mie light scatter simulation in relation to varying emulsion diameter: Within our emulsion 
are micron size aqueous droplets (confirmed from light microscope images suspended in a 
mineral oil and surfactant mixture). As seen in the previous section, the presence of DNA causes 
the destabilization of a droplet. Emulsions are a dynamic system with continuous agitation from 
a micro stir bar. Therefore, we expect that with increasing amount of DNA fragment mixture, the 
diameter size distribution of emulsions will decrease. The method in which real-time change in 
diameter size is monitored is by collecting the bulk light scatter at various angles or angularly 
resolved light scattering with respect to an incident light. Based off the Mie Theory, angularly 
resolved light scatter off a particle gives information to the overall size characteristics of the 
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particle sample[13]. The intensity of light scattered off a particle distribution in relation to 
various diameters (9.42 µm to 0.42 µm) at 30°, 60°, and 90° were simulated to model the 
decreasing diameter size due to increasing presence of DNA amplicons that would be produced 
in an emulsion LAMP reaction. As seen in Figure 1B, light intensity decreases as diameter size 
of emulsions decrease for all 3 angles. The simulation also showed that 30° light scatter had 
higher intensity values, followed by 60°, then 90°. 
 
 
Figure C-1 A) Interfacial tension (IFT) measurements in relation to amount of amplicons 
present at 0, 5, 10, and 20 min of conventional amplification of LAMP reactions via pendant 
droplet analysis. B) Mie scatter simulation of light scatter intensity of a homogeneous particle 
distribution in relation to diameter size at 30°, 60°, and 90° with respect to a 650 nm incident 
light. 
 
Varying LAMP amplicon amount in emulsion platform: As a model sample matrix to 
simulate LAMP amplicon production conventionally amplified LAMP reactions with assay time 
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of 0, 5, 10 , and 20 min were used to determine diameter size and light scatter intensity in 
relation to concentration of DNA present in the emulsion platform. Figure 2A shows the 
diameter distribution between an emulsion sample with various amounts of DNA fragment 
mixture in the emulsion platform after 1 min of agitation. The average diameter size for emulsion 
was 55.57 pixels at 0 min of assay time, 51.43 pixels at 5 min, 18.11 pixels at 10 min, and 21.32 
pixels at 20 min. This resulted in a maximum difference of 67.4% and was statistically different 
between 0 min assay time in comparison to 10 and 20 min conventional amplification assay time. 
Therefore, due to the presence of DNA, emulsion diameter size is decreased due to decreased 
interfacial tension at the oil water interface rendering unstable emulsions, resulting in smaller 
diameters. 
 As demonstrated previously, light scatter, supported by the Mie theory, will change in 
intensity due to size dependencies. In Figure 2B, light scatter intensity at 60° for conventionally 
amplified LAMP reactions with assay times of 0, 5, 10, and 20 min was collected in relation to 
time in emulsion platform. Light scatter intensity at 60° of applied nuclease-free water was also 
collected in the emulsion platform over time, showing lowest initial intensity in comparison to 
LAMP reactions (Supplementary Figure 1). Within the first 30 s, light scatter intensity at 30 s in 
relation to concentration of DNA amount (based on conventional LAMP assay time) shows a 
linear relationship (R2 = 0.976). The percentage change between no DNA fragment mixture 
(nuclease-free water). This linear relationship is further refined at 1 min. Light scatter intensity 
collected at 1 min in relation to conventional LAMP assay time had an R2 vale of 0.976 (Figure 
2C). It can then be alluded, that the decrease in intensity is due to an increase amount of 
amplicon product due to a decrease distribution of emulsion diameter size.  
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Figure C-2. A) Measured diameter from light microscope images of water-oil emulsions 
containing 10 uL conventionally amplified LAMP reaction with assay time of 0, 5, 10, and 20 
min. B) Emulsion light scatter intensity at 60° with respect to 650 nm incident light over time of 
conventionally amplified LAMP reaction with assay time of 0, 5, 10, and 20 min. C) 60° Light 
scatter intensity in relation to conventional LAMP assay time at top: 30s and bottom: 1 min.  
 
Angle-dependent light scatter collection via spectrophotometer: Light scatter intensity from 
fiber optic cables placed at 30°, 60°, and 90° angles with respect to a 650 nm incident light was 
collected from a spectrophotometer of emulsion samples with LAMP reactions containing initial 
bacteria concentrations of 106, 103, 1, and 0 copies per µL. For all 3 angles the underlying trend 
was that light scatter intensity decreased with increasing concentration. This trend is 
synonymous to trends found with light scatter of emulsions containing varying concentration of 
DNA fragment mixture. Light scatter intensities collected at the 30° angle showed the greatest 
difference in change in comparison to NTC (0 copies per µL) for 106 and 103 copies per µL. The 
greatest percent change in light scatter intensity appeared to be 69.7% within 3 minutes on the 
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emulsion platform between 0 and 103 copies per µL. 60° light scatter intensities at different 
initial bacteria concentration did not show significant differences other than 106 copies per µL. 
Light scatter intensity at 3 min shows a 20.63% intensity fluctuation amongst 0 to 103 copies per 
µL concentrations, followed by a significantly different 79.32% intensity change in comparison 
to NTC for 106  copies per µL.  
 
 
Figure C-3. Emulsion LAMP Light scatter intensity via spectrophotometer over time at A) 30° 
and B) 60° angle with respect to 650 nm incident wavelength with varying initial bacteria 
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concentration of 106, 103, 1, and 0 copies per µL. Light scatter intensity at 3 min for C) 30° and 
E) 60° angle for bacteria concentrations of 106, 103, 1, and 0 copies per µL. 
 
 
 
Emulsion light scatter intensity in relation to bacteria concentration with no LAMP 
reagents: Control experiments were conducted on the emulsion platform with the addition of 10 
µL aqueous solutions containing diluted bacteria concentrations of 106, 103, 1, and 0 copies per 
µL with bovine serum albumin (BSA) as a stabilizer. Bacteria solutions with no LAMP reagents 
were used to investigate light scatter changes due to initial adsorption of bacteria cells/fragments 
adsorption rather than nucleic acid amplification. Light scatter intensities were collected at 60° 
over time for four different bacteria concentrations (Figure 4A). Light scatter intensities at 3 min 
are shown in relation to concentration of bacteria solution added to the emulsion platform. 
Overall there is no significant trends, resulting in only a maximum difference in comparison to 0 
CFU per µL of 37.29%. Since there is no significant concentration dependent light scatter 
intensity trends these control experiments results in the assumption that light scatter collected at 
60° angle can be used to determine nucleic acid dependencies rather than initial bacteria 
adsorption.  
 Utilizing the same emulsion samples, 30° light scatter intensities were also collected over 
time (Figure C) and plotted in relation to bacteria concentration at 3 min. Unlike the 60° light 
scatter intensities at 3 min, there was a concentration dependency. The maximum percent change 
difference in light scatter intensities was observed between 1 CFU per µL and 1000 CFU per µL 
at 55.53% at 3 min (Figure D). Therefore, we can conclude that the decrease change in intensity 
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observed in previous emulsion LAMP reactions at 30° was due to bacteria adsorption and not 
amplicon presence. In comparison, since light scatter change in intensity collected at 60° did not 
significantly change in relation to bacteria concentration, 60° angle should be used to monitor 
nucleic acid amplification.  
 
 
Figure C-4. A) Emulsion, no amplification light scatter intensity with relation to time collected 
at 60° angle with respect to a 650 nm wavelength incident light with diluted bacteria and BSA 
droplets varying concentrations of 106, 103, 1, and 0 copies per µL. B) Light scatter intensity at 3 
min collected from 60° angle at 3 min.  
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Angle-dependent light scatter collection via smartphone camera: A 3D printed hot plate 
attachment was designed and fabricated to hold the emulsion reaction chamber and house 2 
blinking red LEDs placed at 30° and 60° angles with respect to a smartphone camera. 10 µL 
LAMP reactions with varying initial bacteria concentrations of 106, 103, 1, and 0 copies per µL 
were placed into the emulsion platform in a similar fashion as the spectrophotometer procedure. 
Images were taken every 3s synced to the differently angled LEDs over the course of 15 min to 
characterize smartphone optical detection as replacement for a spectrophotometer and fiber 
optical cable experimental set up for a more user-friendly platform. Red Channel intensity in the 
captured images were extracted and sorted from time-lapsed image sequence for both angles 
(Figure 5A and 5B). Intensity from these curves were taken in relation to concentration of initial 
target concentration at 3 min and 6 min. Similar trends were found for both angles, as initial 
target concentration increased, intensity decreased. 30° light scatter intensity at 3 and 6 min 
showed a 96.29% and 131.4% change in intensity between NTC and 106 copies per µL (Figure 
5C and 5D). 60° light scatter intensity at 3 and 6 min showed a 93.80% and 102.3% change in 
intensity between NTC and 106 copies per µL (Figure 5E and 5F). 
 Interestingly, the percent changes in intensities in comparison to NTC across bacteria 
concentration collected via smartphone camera were larger in comparison to intensities collected 
via spectrophotometer. This could be due the ability to resolve outlier reactions based off of 
image observations. For example, a reaction was omitted from the data set when a large bubble 
was accidentally introduced into the emulsion. Such omission could not be conducted on a 
spectrophotometer set up because there are no images to confirm such event. However, 
disadvantages to utilizing a smartphone to capture light scatter intensities via time-lapse is it is 
not conducted in a real-time fashion. Images must be taken from the smartphone, uploaded, and 
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processed via an automated Python script. Next steps to address this concern is rather than a 
smartphone as the optical transducer, a microcontroller camera connected to a smartphone user 
interface could be designed as a standalone device.  
 
Figure C-5. Emulsion LAMP Light scatter intensity via smartphone camera over time at A) 30° 
and B) 60° angle with respect to 650 nm incident wavelength with varying initial bacteria 
concentration of 106, 103, 1, and 0 copies per µL.  30° light scatter red channel intensity at C) 3 
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min and D) 6 min. 60° light scatter red channel intensity at E) 3 min and F) 6 min with bacteria 
concentrations of 106, 103, 1, and 0 copies per µL. 
 
Conclusion  
An emulsion platform was investigated to determine angle-dependent light scatter’s 
potential to monitor in real-time the amplification of nucleic acids in an isothermal state via 
LAMP reaction. The phenomenon to attribute to light scatter intensity changes due to amplicon 
presence was verified via pendant droplet analysis for the measurement of interfacial tension 
(IFT). IFT measurements showed that with added LAMP amplicon model samples (DNA 
fragment mixtures ranging from 100 to 2,000 bp) there is a decrease in IFT. Amplicon presence 
destabilizes aqueous droplets due to the increased molecules at the interface. Therefore, we can 
allude that in an emulsion platform, solutions with a larger amplicon presence will have a 
decreased droplet diameter distribution. This was confirmed via light microscope images where 
emulsions diameters with no amplicons (NTC or 0 µg DNA fragment mixture) were 43.6% 
smaller than emulsion diameters with amplicons (1 µg DNA fragment mixture).  
Emulsions with the addition of various amounts of model amplicon solutions showed that 
angle-dependent light intensity at 60° decreases linearly in relation to increased amount of 
amplicons. Mie scatter simulations further confirmed that light scatter intensity is diameter 
dependent. Smaller diameter emulsions will have higher intensity values than larger diameter 
emulsions. LAMP emulsions with varying initial bacteria concentrations were performed while 
light scatter intensity at 30° and 60° were monitored in real time. Intensity light scatter values at 
3 min showed similar trends to the light scatter experiments with DNA fragment mixture 
solutions. At 3 min, 30° light scatter intensity can statistically differentiate 103 and 106 copies per 
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µL initial concentrations in comparison to NTC (0 copies per µL). 6 min light scatter intensities 
collected at 60° can statistically differentiate 106 per µL initial concentrations in comparison to 
NTC (0 copies per µL). 
As a control study to determine if light scatter changes were truly due to amplicon 
adsorption, solutions of varying bacteria concentrations with no LAMP reagents were placed into 
an emulsion and monitored for light scatter. 30°, 3 min light scatter data showed a maximum 
decrease in light scatter of 55.53% alluding to the detection of bacteria adsorption, not amplicon 
presence. In comparison 3 min, 60° light scatter intensities showed not distinguishable bacteria 
concentration dependencies, therefore the decrease in light scatter intensity at 60° was due to 
amplicon presence.  
Furthermore, a 3D printed hot plate attachment with an emulsion reaction chamber, 2 
blinking LEDs placed at 30° and 60°, and smartphone holder was designed and utilized to 
simplify the emulsion platform from spectrophotometers and fiber optical cables to a more user-
friendly platform. Similar light scatter intensities were achieved for both angles and in 
comparison to spectrophotometer collected data, thus demonstrating translatability of emulsion 
LAMP detection technologies toward field-deployability in resource-limited or clinical settings.  
Current challenges to address in platform is to increase the reproducibility so diagnostic 
outcomes due to light scatter changes are more robust under different conditions. This must be 
addressed since application setting/environment is intended for field-use. This was minimally 
introduced in this study since conditions varied such as use of bacteria samples that were stored 
over time for utilization as target samples, oil phase mixtures were prepared on the day of 
experiments by multiple different users, and application of droplet into the emulsion platform 
was done manually by different users. Results showed statistically significant trends regardless 
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of variations introduced in experimental set up, showing promising robustness. However, ways 
to increase reproducibility of the platform, by mitigating sample application variation, is the 
integration of an automated sample loading methodology such as a microfluidic pump or 
automated pipette to aspirate droplet into the emulsion in a controlled manner.  
The platform is advantageous due to its inherent extraction of initial DNA in target 
sample from agitation (micro stir bar), surfactants in oil phase, and use of heat for denaturation 
of bacterial membrane. Therefore, the platform mechanism decreases the pre-processing and 
lysing required to amplify nucleic acid from patient samples. Future work would be to 
demonstrate the platform in a more complex sample matrix such as blood or urine patient 
samples collected for bacterial infection identification, as well as other target pathogenic 
bacteria. 
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